Cover page
Cover page - shares | 3 Months Ended | |
Mar. 31, 2021 | May 14, 2021 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2021 | |
Document Transition Report | false | |
Entity File Number | 000-12436 | |
Entity Registrant Name | COLONY BANKCORP, INC. | |
Entity Incorporation, State or Country Code | GA | |
Entity Tax Identification Number | 58-1492391 | |
Entity Address, Address Line One | 115 South Grant Street | |
Entity Address, City or Town | Fitzgerald | |
Entity Address, State or Province | GA | |
Entity Address, Postal Zip Code | 31750 | |
City Area Code | 229 | |
Local Phone Number | 426-6000 | |
Title of 12(b) Security | Common Stock, Par Value $1.00 per share | |
Trading Symbol | CBAN | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding (in shares) | 9,498,783 | |
Entity Central Index Key | 0000711669 | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2021 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | false |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
ASSETS | ||
Cash and due from banks | $ 16,150 | $ 17,218 |
Federal funds sold | 2,253 | 2,227 |
Interest-bearing deposits in banks | 163,185 | 164,061 |
Cash and cash equivalents | 181,588 | 183,506 |
Investment securities available for sale, at fair value | 433,729 | 380,814 |
Other investments, at cost | 2,703 | 3,296 |
Loans held for sale | 28,429 | 52,386 |
Loans | 1,062,775 | 1,059,503 |
Allowance for loan losses | (12,693) | (12,127) |
Loans, net | 1,050,082 | 1,047,376 |
Premises and equipment | 32,790 | 32,057 |
Other real estate owned | 518 | 1,006 |
Goodwill | 15,992 | 15,992 |
Other intangible assets | 2,096 | 2,271 |
Bank-owned life insurance | 31,581 | 31,547 |
Other assets | 19,538 | 13,723 |
Total assets | 1,799,046 | 1,763,974 |
Deposits | ||
Noninterest-bearing | 384,830 | 326,999 |
Interest-bearing | 1,141,054 | 1,118,028 |
Total deposits | 1,525,884 | 1,445,027 |
Federal Home Loan Bank advances | 22,500 | 22,500 |
Paycheck Protection Program Liquidity Facility | 60,602 | 106,789 |
Other borrowings | 37,542 | 37,792 |
Other liabilities | 9,031 | 7,378 |
Total liabilities | 1,655,559 | 1,619,486 |
Stockholders' equity: | ||
Preferred stock, no par value; 10,000,000 shares authorized, none issued or outstanding as of March 31, 2021 and December 31, 2020, respectively | 0 | 0 |
Common stock, par value $1.00 per share; 20,000,000 shares authorized, 9,498,783 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively | 9,499 | 9,499 |
Paid in capital | 43,224 | 43,215 |
Retained earnings | 88,939 | 84,993 |
Accumulated other comprehensive income, net of tax | 1,825 | 6,781 |
Total stockholders' equity | 143,487 | 144,488 |
Total liabilities and stockholders' equity | $ 1,799,046 | $ 1,763,974 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parentheticals) - $ / shares | Mar. 31, 2021 | Dec. 31, 2020 |
Stockholders' equity: | ||
Preferred Stock, No Par Value (in dollars per share) | $ 0 | $ 0 |
Preferred Stock, Shares Authorized (in shares) | 10,000,000 | 10,000,000 |
Preferred Stock, Shares Issued (in shares) | 0 | 0 |
Preferred Stock, Shares Outstanding (in shares) | 0 | 0 |
Common Stock, Par Value (in dollars per share) | $ 1 | $ 1 |
Common Stock, Shares Authorized (in shares) | 20,000,000 | 20,000,000 |
Common Stock, Shares, Issued (in shares) | 9,498,783 | 9,498,783 |
Common Stock, Shares, Outstanding (in shares) | 9,498,783 | 9,498,783 |
Consolidated Statements of Inco
Consolidated Statements of Income (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Interest income | ||
Loans, including fees | $ 13,573 | $ 13,290 |
Investment securities | 1,750 | 1,994 |
Federal funds sold, deposits with other banks and short term investments | 53 | 284 |
Total interest income | 15,376 | 15,568 |
Interest expense | ||
Deposits | 654 | 2,218 |
Federal Home Loan Bank Advances | 114 | 257 |
Paycheck Protection Program Liquidity Facility | 68 | 0 |
Other borrowings | 257 | 389 |
Total interest expense | 1,093 | 2,864 |
Net interest income | 14,283 | 12,704 |
Provision for loan losses | 500 | 1,956 |
Net interest income after provision for loan losses | 13,783 | 10,748 |
Noninterest income | ||
Gain on sale of SBA loans | 1,471 | 210 |
(Loss) gain on sale of securities | (4) | 293 |
BOLI Income | 208 | 151 |
Other | 154 | 78 |
Total noninterest income | 8,576 | 4,526 |
Noninterest expense | ||
Salaries and employee benefits | 9,955 | 7,498 |
Occupancy and equipment | 1,326 | 1,318 |
Acquisition related expenses | 176 | 287 |
Information technology expenses | 1,592 | 1,316 |
Professional fees | 486 | 347 |
Advertising and public relations | 580 | 634 |
Communications | 218 | 191 |
FHLB prepayment penalty | 0 | 276 |
Other | 1,449 | 1,476 |
Noninterest Expenses | 15,782 | 13,343 |
Income before income taxes | 6,577 | 1,931 |
Income taxes | 1,658 | 328 |
Net income | $ 4,919 | $ 1,603 |
Earnings per common share: | ||
Basic (in dollars per share) | $ 0.52 | $ 0.17 |
Diluted (in dollars per share) | 0.52 | 0.17 |
Dividends declared per share (in dollars per share) | $ 0.1025 | $ 0.10 |
Weighted average number of common shares | ||
Weighted average basic shares outstanding (in shares) | 9,498,783 | 9,498,783 |
Weighted average diluted shares outstanding (in shares) | 9,498,783 | 9,498,783 |
Service charges on deposits | ||
Noninterest income | ||
Noninterest income | $ 1,222 | $ 1,499 |
Mortgage fee income | ||
Noninterest income | ||
Noninterest income | 3,995 | 1,262 |
Interchange fees | ||
Noninterest income | ||
Noninterest income | $ 1,530 | $ 1,033 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Statement of Comprehensive Income [Abstract] | ||
Net income | $ 4,919 | $ 1,603 |
Other comprehensive income: | ||
Unrealized (losses) gains on securities arising during the period | (6,701) | 6,501 |
Tax effect | 1,742 | (1,365) |
Realized losses (gains) on sale of available for sale securities | 4 | (293) |
Tax effect | (1) | 62 |
Change in unrealized (losses) gains on securities available for sale, net of reclassification adjustment and tax effects | (4,956) | 4,905 |
Comprehensive (loss) income | $ (37) | $ 6,508 |
Consolidated Statements of Chan
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands | Total | Common Stock | Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) |
Beginning Balance (in shares) at Dec. 31, 2019 | 9,499 | ||||
Beginning Balance at Dec. 31, 2019 | $ 130,506 | $ 9,499 | $ 43,667 | $ 76,978 | $ 362 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Change in net unrealized (losses) gains on securities available for sale, net of reclassification adjustment and tax effects | 4,905 | 4,905 | |||
Dividends on common shares | (950) | (950) | |||
Stock-based compensation expense | 8 | 8 | |||
Net income | 1,603 | 1,603 | |||
Ending Balance (in shares) at Mar. 31, 2020 | 9,499 | ||||
Ending Balance at Mar. 31, 2020 | 136,072 | $ 9,499 | 43,675 | 77,631 | 5,267 |
Beginning Balance (in shares) at Dec. 31, 2020 | 9,499 | ||||
Beginning Balance at Dec. 31, 2020 | 144,488 | $ 9,499 | 43,215 | 84,993 | 6,781 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Change in net unrealized (losses) gains on securities available for sale, net of reclassification adjustment and tax effects | (4,956) | (4,956) | |||
Dividends on common shares | (973) | (973) | |||
Stock-based compensation expense | 9 | 9 | |||
Net income | 4,919 | 4,919 | |||
Ending Balance (in shares) at Mar. 31, 2021 | 9,499 | ||||
Ending Balance at Mar. 31, 2021 | $ 143,487 | $ 9,499 | $ 43,224 | $ 88,939 | $ 1,825 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Operating Activities | ||
Net income | $ 4,919 | $ 1,603 |
Adjustments reconciling net income to net cash provided by operating activities: | ||
Provision | 500 | 1,956 |
Depreciation, amortization, and accretion | 1,762 | 140 |
Share-based compensation expense | 9 | 8 |
Net change in servicing asset | (290) | 40 |
(Loss) Gain on sale of securities | 4 | (293) |
Gain on sale of SBA loans | (1,471) | (210) |
Loss on sale of other real estate owned | (25) | 0 |
Writedown on other real estate owned | 16 | 125 |
Loss on sale of premises & equipment | 0 | 18 |
Originations of loans held for sale | (105,919) | (30,093) |
Proceeds from sales of loans held for sale | 131,347 | 29,357 |
Change in bank-owned life insurance | (34) | (156) |
Deferred tax benefit | (589) | (292) |
Change in other assets | (3,619) | 525 |
Change in other liabilities | 1,653 | 587 |
Net cash provided by operating activities | 28,263 | 3,315 |
Investing Activities | ||
Purchases of investment securities available for sale | (86,465) | (14,454) |
Proceeds from maturities, calls, and paydowns of investment securities available for sale | 24,819 | 20,022 |
Proceeds from sale of investment securities available for sale | 1,643 | 15,314 |
Net loans | (3,525) | (20,932) |
Purchase of premises and equipment | (1,300) | (649) |
Proceeds from sale of other real estate owned | 607 | 813 |
Redemption of Federal Home Loan Bank Stock | 593 | 397 |
Proceeds from sale of premises and equipment | 0 | 25 |
Net cash (used in) investing activities | (63,628) | 536 |
Financing Activities | ||
Change in noninterest-bearing customer deposits | 57,831 | 2,634 |
Change in interest-bearing customer deposits | 23,026 | (3,300) |
Dividends paid for common stock | (973) | (950) |
Payment on Paycheck Protection Program Liquidity Fund | (46,187) | 0 |
Payments on Federal Home Loan Bank Advances | 0 | (24,500) |
Proceeds from Federal Home Loan Bank Advances | 0 | 14,000 |
Payments on Other borrowings | (250) | 0 |
Net cash provided by (used in) financing activities | 33,447 | (12,116) |
Net decrease in cash and cash equivalents | (1,918) | (8,265) |
Cash and cash equivalents at beginning of period | 183,506 | 104,092 |
Cash and cash equivalents at end of period | 181,588 | 95,827 |
Supplemental Disclosure of Cash Flow Information | ||
Cash paid during the period for interest | 994 | 2,867 |
Acquisition of real estate through foreclosure | $ 110 | $ 465 |
Consolidated Statements of Ch_2
Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) - $ / shares | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Statement of Stockholders' Equity [Abstract] | ||
Dividends declared per share (in dollars per share) | $ 0.1025 | $ 0.10 |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2021 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies Presentation Colony Bankcorp, Inc. (the “Company”) is a bank holding company located in Fitzgerald, Georgia. The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Colony Bank, Fitzgerald, Georgia (the “Bank”). The “Company” or “our,” as used herein, includes Colony Bank, except where the content requires otherwise. In July 2019, a new subsidiary of the Company was incorporated under the name Colony Risk Management, Inc. Colony Risk Management, Inc. is a subsidiary of the Company and is located in Las Vegas, Nevada. It is a captive insurance subsidiary which insures various liability and property damage policies for the Company and its related subsidiaries. Colony Risk Management is regulated by the State of Nevada Division of Insurance. All adjustments consisting of normal recurring accruals which are, in the opinion of management, necessary for fair presentation of the interim consolidated financial statements, have been included and fairly and accurately present the financial position, results of operations and cash flows of the Company. All significant intercompany accounts have been eliminated in consolidation. The accounting and reporting policies of the Company conform to generally accepted accounting principles and practices utilized in the commercial banking industry for interim financial information and Regulation S-X. Accordingly, the accompanying unaudited interim consolidated financial statements do not include all of the information or notes required for complete financial statements. The results of operations for the three months ended March 31, 2021 are not necessarily indicative of the results which may be expected for the year ending December 31, 2021. These statements should be read in conjunction with the consolidated financial statements and notes thereto in the Company's Annual Report on Form 10-K for the year ended December 31, 2020 (“2020 10-K”). Nature of Operations The Bank provides a full range of retail, commercial and mortgage banking services for consumers and small- to medium-size businesses located primarily in central, south and coastal Georgia. The Bank is headquartered in Fitzgerald, Georgia with banking and mortgage offices in Albany, Ashburn, Athens, Broxton, Centerville, Columbus, Cordele, Douglas, Eastman, Fitzgerald, LaGrange, Leesburg, Macon, Moultrie, Quitman, Rochelle, Savannah, Soperton, Sylvester, Statesboro, Tifton, Valdosta and Warner Robins. Lending and investing activities are funded primarily by deposits gathered through its retail banking office network. Use of Estimates In preparing the consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the balance sheet date and revenues and expenses for the period. Actual results could differ significantly from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the determination of the allowance for loan losses, the valuation of real estate acquired in connection with foreclosures or in satisfaction of loans and fair value of assets acquired and liabilities assumed in a business combination, including goodwill impairment. Reclassifications In certain instances, amounts reported in prior years’ consolidated financial statements have been reclassified to conform to statement presentations selected for 2021. Such reclassifications have not materially affected previously reported stockholders’ equity or net income. Concentrations of Credit Risk Concentrations of credit risk can exist in relation to individual borrowers or groups of borrowers, certain types of collateral, certain types of industries, or certain geographic regions. The Company has a concentration in real estate loans as well as a geographic concentration that could pose an adverse credit risk. At March 31, 2021, approximately 78% of the Company’s loan portfolio was concentrated in loans secured by real estate. A substantial portion of borrowers’ ability to honor their contractual obligations is dependent upon the viability of the real estate economic sector. Management continues to monitor these concentrations and has considered these concentrations in its allowance for loan loss analysis. The success of the Company is dependent, to a certain extent, upon the economic conditions in the geographic markets it serves. Adverse changes in the economic conditions in these geographic markets would likely have a material adverse effect on the Company’s results of operations and financial condition. The operating results of the Company depend primarily on its net interest income. Accordingly, operations are subject to risks and uncertainties surrounding the exposure to changes in the interest rate environment. At times, the Company may have cash and cash equivalents at financial institutions in excess of federal deposit insurance limits. The Company places its cash and cash equivalents with high credit quality financial institutions whose credit ratings are monitored by management to minimize credit risk. Changes in Accounting Principles and Effects of New Accounting Pronouncements ASU 2016-13, Financial Instruments – Credit Losses (Topic 326). This ASU sets forth a “current expected credit loss” (CECL) model which requires the Company to measure all expected credit losses for financial instruments held at the reporting date based on historical experience, current conditions and reasonable supported forecasts. This replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost and applies to some off-balance sheet credit exposures. This ASU is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. On October 16, 2019, the Financial Accounting Standards Board ("FASB") voted to extend the delay of the effective date of this ASU for smaller reporting companies, such as the Company, until fiscal years beginning after December 15, 2022. The Company is currently assessing the impact of the adoption of this ASU on its consolidated financial statements. In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740) : Simplifying the Accounting for Income Taxes. This update removes several exceptions related to intraperiod tax allocation when there is a loss from continuing operations and income from other items, foreign subsidiaries becoming equity method investments and vice versa, and calculating income taxes in an interim period when a year-to-date loss exceeds the anticipated loss for the year. The guidance also amends requirements related to franchise tax that is partially based on income, a step up in the tax basis of goodwill, allocation of consolidated tax expense to a legal entity not subject to tax in its separate financial statements, the effects of enacted changes in tax laws and other minor codification improvements regarding employee stock ownership plans and investments in qualified affordable housing projects. For public entities, this guidance is effective for fiscal years beginning after December 15, 2020. The adoption of this standard did not have a material impact on the consolidated financial statements. In January 2020, the FASB issued ASU No. 2020-01, Investments—Equity Securities (Topic 321), Investments—Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)—Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force) . This update clarifies whether an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative and how to account for certain forward contracts and purchased options to purchase securities. For public entities, this guidance is effective for fiscal years beginning after December 15, 2020. The adoption of this standard did not have a material impact on the consolidated financial statements. In March 2020, the FASB issued ASU No. 2020-04, Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting ("ASU 2020-04"). ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March 12, 2020 through December 31, 2022. The adoption of this standard did not have a material impact on the consolidated financial statements. Operating, Accounting and Reporting Considerations Related to COVID-19 The COVID-19 pandemic has negatively impacted the global economy, including the Company’s primary metropolitan markets. In response to this crisis, the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act was passed by Congress and signed into law on March 27, 2020. The CARES Act provides an estimated $2.2 trillion to fight the COVID-19 pandemic and stimulate the economy by supporting individuals and businesses through loans, grants, tax changes, and other types of relief. Some of the provisions applicable to the Company include, but are not limited to: • Accounting for Loan Modifications - The CARES Act provides that financial institutions may elect to suspend (1) the requirements under GAAP for certain loan modifications that would otherwise by categorized as a troubled debt restructure (“TDR”) and (2) any determination that such loan modifications would be considered a TDR, including the related impairment for accounting purposes. • Paycheck Protection Program - The CARES Act established the Paycheck Protection Program (“PPP”), an expansion of the Small Business Administration’s 7(a) loan program and the Economic Injury Disaster Loan Program (“EIDL”), administered directly by the SBA. Also in response to the COVID-19 pandemic, the Board of Governors of the Federal Reserve System (“FRB”), the Federal Deposit Insurance Corporation (“FDIC”), the National Credit Union Administration (“NCUA”), the Office of the Comptroller of the Currency (“OCC”), and the Consumer Financial Protection Bureau (“CFPB”), in consultation with the state financial regulators (collectively, the “agencies”) issued a joint interagency statement (issued March 22, 2020; revised statement issued April 7, 2020). Some of the provisions applicable to the Company include, but are not limited to: • Accounting for Loan Modifications - Loan modifications that do not meet the conditions of the CARES Act may still qualify as a modification that does not need to be accounted for as a TDR. The agencies confirmed with FASB staff that short-term modifications made on a good faith basis in response to COVID-19 to borrowers who were current prior to any relief are not TDRs. This includes short-term (e.g., three months) modifications such as payment deferrals, fee waivers, extensions of repayment terms, or insignificant delays in payment, as long as such modifications are (1) related to COVID-19; (2) executed on a loan that was not more than 30 days past due as of December 31, 2019; and (3) executed between March 1, 2020, and the earlier of (a) 60 days after the date of termination of the national emergency declaration or (b) December 31, 2020. • Past Due Reporting - With regard to loans not otherwise reportable as past due, financial institutions are not expected to designate loans with deferrals granted due to COVID-19 as past due because of the deferral. A loan’s payment date is governed by the due date stipulated in the legal agreement. If a financial institution agrees to a payment deferral, these loans would not be considered past due reporting during the period of the deferral. • Nonaccrual Status and Charge-offs - During short-term COVID-19 modifications, these loans generally should not be reported as nonaccrual or as classified. As such, beginning in late March 2020, the Company provided relief programs consisting primarily of 90-day payment deferral relief of principal and interest to borrowers negatively impacted by COVID-19 and has accounted for these loan modifications in accordance with ASC 310-40. In addition, the Company also provided principal only payment deferral relief to borrowers of which interest income has been recognized during the deferment period on these interest-only loans. |
Investment Securities
Investment Securities | 3 Months Ended |
Mar. 31, 2021 | |
Investments, Debt and Equity Securities [Abstract] | |
Investment Securities | Investment Securities The amortized cost and estimated fair value of securities available for sale along with gross unrealized gains and losses are summarized as follows: (dollars in thousands) March 31, 2021 Amortized Gross Gross Fair Value Securities Available for Sale: U.S. treasury securities $ 245 $ — $ — $ 245 U.S. agency 9,863 11 (70) 9,804 Mutual fund 3,998 — — 3,998 State, county & municipal securities 73,041 356 (1,073) 72,324 Corporate debt securities 5,250 1 (22) 5,229 Mortgage-backed securities 338,990 5,514 (2,375) 342,129 $ 431,387 $ 5,882 $ (3,540) $ 433,729 December 31, 2020 Securities Available for Sale: U.S. treasury securities $ 245 $ — $ — $ 245 U.S. agency 1,000 4 — 1,004 State, county & municipal securities 61,298 1,155 (65) 62,388 Corporate debt securities 4,250 1 (1) 4,250 Mortgage-backed securities 305,438 7,837 (348) 312,927 $ 372,231 $ 8,997 $ (414) $ 380,814 The amortized cost and fair value of investment securities as of March 31, 2021, by contractual maturity, are shown hereafter. Expected maturities may differ from contractual maturities for certain investments because issuers may have the right to call or prepay obligations with or without call or prepayment penalties. This is often the case with mortgage-backed securities, which are disclosed separately in the table below. Securities Available for Sale (dollars in thousands) Amortized Cost Fair Value Due in one year or less $ 6,243 $ 6,244 Due after one year through five years 1,910 1,948 Due after five years through ten years 33,362 33,152 Due after ten years 50,882 50,256 $ 92,397 $ 91,600 Mortgage-backed securities 338,990 342,129 $ 431,387 $ 433,729 Proceeds from the sale of investment securities totaled $1.6 million and $15.3 million for the three months ended March 31, 2021 and 2020, respectively. The sale of investment securities for the three months ended March 31, 2021 and 2020 resulted in gross realized gains of $1,000 and $314,000 and losses of $5,000 and $215,000, respectively. Investment securities having a carrying value approximating $117.7 million and $126.5 million were pledged to secure public deposits and for other purposes as of March 31, 2021 and December 31, 2020, respectively. Information pertaining to securities with gross unrealized losses at March 31, 2021 and December 31, 2020 aggregated by investment category and length of time that individual securities have been in a continuous loss position, follows: Less Than 12 Months 12 Months or Greater Total (dollars in thousands) Fair Gross Fair Gross Fair Gross March 31, 2021 U.S. agency $ 8,662 $ (70) $ — $ — $ 8,662 $ (70) State, county & municipal securities 47,942 (1,073) — — 47,942 (1,073) Corporate debt securities 1,728 (22) — — 1,728 (22) Mortgage-backed securities 120,777 (2,159) 4,005 (216) 124,782 (2,375) $ 170,447 $ (3,254) $ 4,005 $ (216) $ 174,452 $ (3,470) December 31, 2020 State, county & municipal securities $ 8,282 $ (65) $ — $ — $ 8,282 $ (65) Corporate debt securities 999 (1) — — 999 (1) Mortgage-backed securities 28,835 (77) 3,949 (271) 32,784 (348) $ 38,116 $ (143) $ 3,949 $ (271) $ 42,065 $ (414) Management evaluates securities for other-than-temporary impairment at least on a quarterly basis, and more frequently when economic or market concerns warrant such evaluation. Consideration is given to (1) the length of time and the extent to which the fair value has been less than cost, (2) the financial condition and near-term prospects of the issuer and (3) the intent and ability of the Company to retain its investment in the issuer for a period of time sufficient to allow for any anticipated recovery in fair value. |
Loans
Loans | 3 Months Ended |
Mar. 31, 2021 | |
Receivables [Abstract] | |
Loans | Loans The following table presents the composition of loans segregated by legacy and purchased loans and by class of loans, as of March 31, 2021 and December 31, 2020. Purchased loans are defined as loans that were acquired in bank acquisitions. March 31, 2021 (dollars in thousands) Legacy Loans Purchased Loans Total Construction, land and land development $ 109,585 $ 6,383 $ 115,967 Other commercial real estate 499,604 38,477 538,080 Total commercial real estate 609,189 44,860 654,047 Residential real estate 165,887 12,324 178,211 Commercial, financial, & agricultural (*) 199,862 10,452 210,315 Consumer and other 18,055 2,147 20,202 Total Loans $ 992,993 $ 69,783 $ 1,062,775 December 31, 2020 (dollars in thousands) Legacy Loans Purchased Loans Total Construction, land and land development $ 109,577 $ 11,516 $ 121,093 Other commercial real estate 477,445 42,946 520,391 Total commercial real estate 587,022 54,462 641,484 Residential real estate 167,714 15,307 183,021 Commercial, financial, & agricultural (*) 200,800 12,580 213,380 Consumer and other 19,037 2,581 21,618 Total Loans $ 974,573 $ 84,930 $ 1,059,503 (*) Includes $102.6 million and $101.1 million in PPP loans at March 31, 2021 and December 31, 2020 Commercial and industrial loans are extended to a diverse group of businesses within the Company’s market area. These loans are often underwritten based on the borrower’s ability to service the debt from income from the business. Real estate construction loans often require loan funds to be advanced prior to completion of the project. Due to uncertainties inherent in estimating construction costs, changes in interest rates and other economic conditions, these loans often pose a higher risk than other types of loans. Consumer loans are originated at the Bank level. Credit Quality Indicators . As part of the ongoing monitoring of the credit quality of the loan portfolio, management tracks certain credit quality indicators including trends related to (1) the risk grade assigned to commercial and consumer loans, (2) the level of classified commercial loans, (3) net charge-offs, (4) nonperforming loans, and (5) the general economic conditions in the Company’s geographic markets. The Company uses an eight category risk grading system to assign a risk grade to each loan in the portfolio. The following is a description of the general characteristics of the grades: • Grades 1 and 2 – Borrowers with these assigned grades range in risk from virtual absence of risk to minimal risk. Such loans may be secured by Company-issued and controlled certificates of deposit or properly margined equity securities or bonds. Other loans comprising these grades are made to companies that have been in existence for a long period of time with many years of consecutive profits and strong equity, good liquidity, excellent debt service ability and unblemished past performance, or to exceptionally strong individuals with collateral of unquestioned value that fully secures the loans. Loans in this category fall into the “pass” classification. • Grades 3 and 4 – Loans assigned these “pass” risk grades are made to borrowers with acceptable credit quality and risk. The risk ranges from loans with no significant weaknesses in repayment capacity and collateral protection to acceptable loans with one or more risk factors considered to be more than average. • Grade 5 – This grade includes “special mention” loans on management’s watch list and is intended to be used on a temporary basis for pass grade loans where risk-modifying action is intended in the short-term. • Grade 6 – This grade includes “substandard” loans in accordance with regulatory guidelines. This category includes borrowers with well-defined weaknesses that jeopardize the payment of the debt in accordance with the agreed terms. Loans considered to be impaired are assigned this grade, and these loans often have assigned loss allocations as part of the allowance for loan and lease losses. Generally, loans on which interest accrual has been stopped would be included in this grade. • Grades 7 and 8 – These grades correspond to regulatory classification definitions of “doubtful” and “loss,” respectively. In practice, any loan with these grades would be for a very short period of time, of which the Company has no loans with these assigned grades at March 31, 2021. Management manages the Company’s problem loans in such a way that uncollectible loans or uncollectible portions of loans are charged off immediately with any residual, collectible amounts assigned a risk grade of 6. The following table presents the loan portfolio, excluding purchased loans, by credit quality indicator (risk grade) as of March 31, 2021 and December 31, 2020. Those loans with a risk grade of 1, 2, 3 or 4 have been combined in the pass column for presentation purposes. (dollars in thousands) Pass Special Mention Substandard Total Loans March 31, 2021 Construction, land and land development $ 98,634 $ 3,244 $ 7,707 $ 109,585 Other commercial real estate 452,356 30,301 16,946 499,604 Total commercial real estate 550,990 33,545 24,653 609,189 Residential real estate 156,665 3,090 6,132 165,887 Commercial, financial, & agricultural 196,052 2,795 1,015 199,862 Consumer and other 17,762 129 164 18,055 Total Loans $ 921,469 $ 39,559 $ 31,964 $ 992,993 (dollars in thousands) December 31, 2020 Construction, land and land development $ 99,430 $ 2,940 $ 7,207 $ 109,577 Other commercial real estate 430,515 33,579 13,351 477,445 Total commercial real estate 529,945 36,519 20,558 587,022 Residential real estate 157,927 3,855 5,932 167,714 Commercial, financial, & agricultural 196,749 2,870 1,181 200,800 Consumer and other 18,734 124 179 19,037 Total Loans $ 903,355 $ 43,368 $ 27,850 $ 974,573 December 31, 2020 The following table presents the purchased loan portfolio by credit quality indicator (risk grade) as of March 31, 2021 and December 31, 2020. Those loans with a risk grade of 1, 2, 3 or 4 have been combined in the pass column for presentation purposes. For the period ending March 31, 2021, the Company did not have any loans classified as “doubtful” or a “loss”. (dollars in thousands) Pass Special Mention Substandard Total Loans March 31, 2021 Construction, land and land development $ 6,263 $ 120 $ — $ 6,383 Other commercial real estate 32,391 3,423 2,663 38,477 Total commercial real estate 38,654 3,543 2,663 44,860 Residential real estate 11,944 301 78 12,324 Commercial, financial, & agricultural 8,283 1,690 480 10,452 Consumer and other 2,143 4 — 2,147 Total Loans $ 61,024 $ 5,538 $ 3,221 $ 69,783 December 31, 2020 Construction, land and land development $ 11,275 $ 241 $ — $ 11,516 Other commercial real estate 40,825 53 2,068 42,946 Total commercial real estate 52,100 294 2,068 54,462 Residential real estate 14,909 312 86 15,307 Commercial, financial, & agricultural 10,198 1,803 579 12,580 Consumer and other 2,364 25 192 2,581 Total Loans $ 79,571 $ 2,434 $ 2,925 $ 84,930 A loan’s risk grade is assigned at loan origination and is based on the financial strength of the borrower and the type of collateral. Loan risk grades are subject to review at various times throughout the year as part of the Company’s ongoing loan review process. Loans with an assigned risk grade of six or below and an outstanding balance of $250,000 or more are reassessed on a quarterly basis. During this reassessment process individual reserves may be identified and placed against certain loans which are not considered impaired. In assessing the overall economic condition of the markets in which it operates, the Company monitors the unemployment rates for its major service areas. The unemployment rates are reviewed on a quarterly basis as part of the allowance for loan loss determination. Loans are placed on nonaccrual status if principal or interest payments become 90 days past due or when, in management’s opinion, the borrower may be unable to meet payment obligations as they become due, as well as when required by regulatory guidelines. Loans may be placed on nonaccrual status regardless of whether or not such loans are considered past due. The following table presents the aging of the amortized cost basis in legacy loans by aging category and accrual status as of March 31, 2021 and December 31, 2020: (dollars in thousands) 30-89 Days 90 Days Total Accruing Nonaccrual Current Loans Total Loans March 31, 2021 Construction, land and land development $ 24 $ — $ 24 $ 74 $ 109,487 $ 109,585 Other commercial real estate 108 — 108 5,154 494,342 499,604 Total commercial real estate 132 — 132 5,228 603,829 609,189 Residential real estate 471 — 471 2,572 162,844 165,887 Commercial, financial, & agricultural 149 — 149 810 198,903 199,862 Consumer and other 37 — 37 88 17,930 18,055 Total Loans $ 789 $ — $ 789 $ 8,698 $ 983,506 $ 992,993 December 31, 2020 Construction, land and land development $ 1,314 $ — $ 1,314 $ 80 $ 108,183 $ 109,577 Other commercial real estate 229 — 229 2,545 474,671 477,445 Total commercial real estate 1,543 — 1,543 2,625 582,854 587,022 Residential real estate 667 — 667 2,873 164,174 167,714 Commercial, financial, & agricultural 150 — 150 1,010 199,640 200,800 Consumer and other 48 — 48 102 18,887 19,037 Total Loans $ 2,408 $ — $ 2,408 $ 6,610 $ 965,555 $ 974,573 The following table presents the aging of the amortized cost basis in purchased loans by aging category and accrual status as of March 31, 2021 and December 31, 2020: (dollars in thousands) 30-89 Days 90 Days Total Accruing Nonaccrual Current Loans Total Loans March 31, 2021 Construction, land and land development $ — $ — $ — $ — $ 6,383 $ 6,383 Other commercial real estate — — — 1,883 36,594 38,477 Total commercial real estate — — — 1,883 42,977 44,860 Residential real estate 17 — 17 69 12,238 12,324 Commercial, financial, & agricultural 27 — 27 27 10,398 10,452 Consumer and other — — — — 2,147 2,147 Total Loans $ 44 $ — $ 44 $ 1,979 $ 67,760 $ 69,783 December 31, 2020 Construction, land and land development $ — $ — $ — $ 117 $ 11,399 $ 11,516 Other commercial real estate 544 — 544 2,068 40,334 42,946 Total commercial real estate 544 — 544 2,185 51,733 54,462 Residential real estate 15 — 15 85 15,207 15,307 Commercial, financial, & agricultural 125 — 125 55 12,400 12,580 Consumer and other — — — 193 2,388 2,581 Total Loans $ 684 $ — $ 684 $ 2,518 $ 81,728 $ 84,930 The following table details impaired loan data, including purchased credit impaired loans, as of March 31, 2021. March 31, 2021 (dollars in thousands) Unpaid Recorded Investment Related Average With No Related Allowance Recorded Construction, land and land development $ 7,480 $ 7,480 $ — $ 7,231 Commercial real estate 10,979 10,121 — 11,042 Residential real estate 1,047 1,067 — 1,084 Commercial, financial & agriculture 3 3 — 21 Consumer & other — — — — 19,509 18,671 — 19,378 With An Allowance Recorded Construction, land and land development — — — — Commercial real estate 5,242 5,247 1,315 5,783 Residential real estate 1,177 1,233 229 1,203 Commercial, financial & agriculture 86 86 38 198 Consumer & other 6 6 6 3 6,511 6,572 1,588 7,187 Purchased Credit Impaired Loans Construction, land and land development 116 48 38 71 Commercial real estate 780 764 42 382 Residential real estate 13 1 10 6 Commercial, financial & agriculture 247 27 100 37 Consumer & other — — — 48 1,156 840 190 544 Total Construction, land and land development 7,596 7,528 38 7,302 Commercial real estate 17,001 16,132 1,357 17,207 Residential real estate 2,237 2,301 239 2,293 Commercial, financial & agriculture 336 116 138 256 Consumer & other 6 6 6 51 $ 27,176 $ 26,083 $ 1,778 $ 27,109 The following table details impaired loan data as of December 31, 2020. December 31, 2020 (dollars in thousands) Unpaid Recorded Investment Related Average With No Related Allowance Recorded Construction, land and land development $ 6,969 $ 6,982 $ — $ 2,841 Commercial real estate 11,978 11,105 — 12,190 Residential real estate 1,140 1,122 — 2,142 Commercial, financial & agriculture 42 40 — 203 Consumer & other — — — 123 20,129 19,249 — 17,499 With An Allowance Recorded Construction, land and land development — — — — Commercial real estate 6,292 6,325 1,436 5,945 Residential real estate 1,274 1,230 226 703 Commercial, financial & agriculture 310 310 263 1,118 Consumer & other — — — — 7,876 7,865 1,925 7,766 Purchased Credit Impaired Loans Construction, land and land development 118 94 — 96 Commercial real estate — — — 63 Residential real estate 14 11 4 13 Commercial, financial & agriculture 55 46 — 49 Consumer & other 192 96 81 113 379 247 85 334 Total Construction, land and land development 7,087 7,076 — 2,937 Commercial real estate 18,270 17,430 1,436 18,198 Residential real estate 2,428 2,363 230 2,858 Commercial, financial & agriculture 407 396 263 1,370 Consumer & other 192 96 81 236 $ 28,384 $ 27,361 $ 2,010 $ 25,599 Interest income recorded on impaired loans during the three months ended March 31, 2021 and 2020 were $238,000 and $50,000, respectively. Troubled Debt Restructurings The restructuring of a loan is considered a troubled debt restructuring ("TDRs") if both the borrower is experiencing financial difficulties and the Company has granted a concession to the terms of the loan. Concessions may include interest rate reductions to below market interest rates, principal forgiveness, restructuring amortization schedules and other actions intended to minimize potential losses. As discussed in Note 1 of the Notes to Consolidated Financial Statements for the year ended December 31, 2020, which are included in the Company’s 2020 Form 10-K, once a loan is identified as a TDR, it is accounted for as an impaired loan. The Company had no unfunded commitments to lend to a customer that has a troubled debt restructured loan as of March 31, 2021. The Company had one construction, land and land development loan restructured during the three month periods ended March 31, 2021 for $511,000. Loans modified in a troubled debt restructuring are considered to be in default once the loan becomes 90 days past due. A TDR may cease being classified as impaired if the loan is subsequently modified at market terms and, has performed according to the modified terms for at least six months, and there has not been any prior principal forgiveness on a cumulative basis. The Company had no loans that subsequently defaulted during the three months ended March 31, 2021 and 2020. Modifications in Response to COVID-19 Certain borrowers are currently unable to meet their contractual payment obligations because of the adverse effects of the COVID-19 pandemic. To help mitigate these effects, loan customers may apply for a deferral of payments, or portions thereof, for up to three months. In the absence of other intervening factors, such short-term modifications made on a good faith basis are not categorized as troubled debt restructurings, nor are loans granted payment deferrals related to the COVID-19 pandemic reported as past due or placed on nonaccrual status (provided the loans were not past due or on nonaccrual status prior to the deferral). |
Allowance for Loan Losses
Allowance for Loan Losses | 3 Months Ended |
Mar. 31, 2021 | |
Receivables [Abstract] | |
Allowance for Loan Losses | Allowance for Loan Losses The following tables detail activity in the allowance for loan losses, segregated by class of loan, for the three months periods ended March 31, 2021 and March 31, 2020. Allocation of a portion of the allowance to one category of loans does not preclude its availability to absorb losses in other loan categories and periodically may result in reallocation within the provision categories. (dollars in thousands) Construction, land and land development Other commercial real estate Residential real estate Commercial, financial & agricultural Consumer and other Total Three months ended March 31, 2021 Beginning Balance $ 1,013 $ 6,880 $ 2,278 $ 1,713 $ 243 $ 12,127 Charge-offs — — — (15) (11) (26) Recoveries 15 — 66 3 8 92 Provision 25 248 67 (35) 195 500 Ending balance 1,053 7,128 2,411 1,666 435 12,693 Period end amount allocated to Individually evaluated for impairment — 1,315 229 38 6 1,588 Collectively evaluated for impairment 1,015 5,771 2,172 1,528 429 10,915 Purchase credit impaired 38 42 10 100 — 190 Ending Balance 1,053 7,128 2,411 1,666 435 12,693 Loans Individually evaluated for impairment 7,480 15,368 2,300 89 6 25,243 Collectively evaluated for impairment 108,439 521,948 175,910 210,199 20,196 1,036,692 Purchase credit impaired 48 764 1 27 — 840 Ending balance $ 115,967 $ 538,080 $ 178,211 $ 210,315 $ 20,202 $ 1,062,775 (dollars in thousands) Construction, land and land development Other commercial real estate Residential real estate Commercial, financial & agricultural Consumer and other Total Three months ended March 31, 2020 Beginning Balance $ 215 $ 3,908 $ 980 $ 1,657 $ 103 $ 6,863 Charge-offs — (30) (64) (68) (351) (513) Recoveries 13 5 4 1 55 78 Provision 126 938 283 190 419 1,956 Ending balance 354 4,821 1,203 1,780 226 8,384 December 31, 2020 Period end amount allocated to Individually evaluated for impairment — 1,436 226 263 — 1,925 Collectively evaluated for impairment 1,013 5,444 2,048 1,450 162 10,117 Purchase credit impaired — — 4 — 81 85 Ending Balance 1,013 6,880 2,278 1,713 243 12,127 Loans Individually evaluated for impairment 6,982 17,430 2,352 350 — 27,114 Collectively evaluated for impairment 114,017 502,961 180,658 212,984 21,522 1,032,142 Purchase credit impaired 94 — 11 46 96 247 Ending Balance $ 121,093 $ 520,391 $ 183,021 $ 213,380 $ 21,618 $ 1,059,503 Management continually evaluates the allowance for loan losses methodology seeking to refine and enhance this process as appropriate, and it is likely that the methodology will continue to evolve over time. |
Leases
Leases | 3 Months Ended |
Mar. 31, 2021 | |
Leases [Abstract] | |
Leases | Leases A lease is defined as a contract, or part of a contract, that conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. On January 1, 2019, the Company adopted ASU No. 2016-02 and all subsequent ASUs that modified this topic (collectively referred to as “Topic 842”). For the Company, Topic 842 primarily affected the accounting treatment for operating lease agreements in which the Company is the lessee. Substantially all of the leases in which the Company is the lessee are comprised of real estate for branches and office space with terms extending through 2027. All leases are classified as operating leases, and therefore, were previously not recognized on the Company’s consolidated balance sheet. With the adoption of Topic 842, operating lease arrangements are required to be recognized on the consolidated balance sheet as a right-of-use (“ROU”) asset and a corresponding lease liability. The following table represents the consolidated balance sheet classification of the Company’s ROU assets and liabilities. The Company elected not to include short-term leases (i.e., leases with initial terms of twelve months or less), or equipment leases (deemed immaterial) on the consolidated balance sheet. (dollars in thousands) Classification March 31, 2021 December 31, 2020 Assets Operating lease right-of-use assets Other assets $ 193 $ 511 Liabilities Operating lease liabilities Other liabilities 196 517 The calculated amount of the ROU assets and lease liabilities in the table above are impacted by the length of the lease term and the discount rate used to present value the minimum lease payments. The Company’s lease agreements often include one or more options to renew at the Company’s discretion. If at lease inception the Company considers the exercising of a renewal option to be reasonably certain, the Company will include the extended term in the calculation of the ROU asset and lease liability. Regarding the discount rate, Topic 842 requires the use of the rate implicit in the lease whenever this rate is readily determinable. As this rate is rarely determinable, the Company utilizes its incremental borrowing rate at lease inception, on a collateralized basis, over a similar term. For operating leases existing prior to January 1, 2020, the rate for the remaining lease term as of January 1, 2020 was used. Operating lease cost was $59,000 and $31,000 for the three months ended March 31, 2021 and 2020, respectively. As of March 31, 2021, the weighted average remaining lease term was 1.74 years and the weighted average discount rate was 1.34%. The following table represents the future maturities of the operating lease liabilities and other lease information as of March 31, 2021. (dollars in thousands) Lease Liability 2021 $ 115 2022 83 Total lease payments $ 198 Less: interest (2) Present value of lease liabilities $ 196 Supplemental lease information: Cash paid for amounts included in the measurement of lease liabilities: March 31, 2021 March 31, 2020 Operating cash flows from operating leases (cash payments) $ 58 $ 50 Operating cash flows from operating leases (lease liability addition) — 42 Operating lease right-of-use assets obtained in exchange for leases entered into during the period — 195 |
Borrowings
Borrowings | 3 Months Ended |
Mar. 31, 2021 | |
Debt Disclosure [Abstract] | |
Borrowings | Borrowings The following table presents information regarding the Company’s outstanding borrowings at March 31, 2021 and December 31, 2020: (dollars in thousands) March 31, 2021 December 31, 2020 Federal Home Loan Bank advances $ 22,500 $ 22,500 Paycheck Protection Program (PPP) Liquidity Facility 60,602 106,789 Other borrowings 37,542 37,792 $ 120,644 $ 167,081 Advances from the Federal Home Loan Bank (“FHLB”) have maturities ranging from 2021 to 2029 and interest rates ranging from 1.05% to 3.51%. As collateral on the outstanding FHLB advances, the Company has provided a blanket lien on its portfolio of qualifying residential first mortgage loans, commercial loans, multifamily loans and HELOC loans. At March 31, 2021, the lendable collateral of those loans pledged is $88.6 million. At March 31, 2021, the Company had remaining credit availability from the FHLB of $417.7 million. The Company may be required to pledge additional qualifying collateral in order to utilize the full amount of the remaining credit line. On May 1, 2019, the Company entered into two borrowing arrangements with a correspondent bank for $10.0 million each. The term note is secured by the Bank’s stock, expires on May 1, 2024, and bears a fixed interest rate of 4.70%. The line of credit is secured by the Bank’s stock, expires on July 30, 2021, and bears a variable interest rate of Wall Street Journal Prime minus 0.40%.The proceeds were used for the acquisition of LBC Bancshares, Inc. and its subsidiary, Calumet Bank. As of March 31, 2021, the outstanding balance totaled $8.0 million and $5.3 million. On April 20, 2020 the Company completed a Paycheck Protection Program Liquidity Facility (PPPLF) credit arrangement with The Federal Reserve Bank. This line of credit is secured by PPP loans and bears a fixed interest rate of 0.35% with a maturity date equal to the maturity date of the related PPP loans, with the PPP loans maturing either two The aggregate stated maturities of other borrowed money at March 31, 2021 are as follows: (dollars in thousands) Year Amount 2021 $ 5,313 2022 — 2023 3,000 2024 8,000 2025 4,500 2026 and After 39,229 PPPLF 60,602 $ 120,644 The Company also has available federal funds lines of credit with various financial institutions totaling $41.5 million, none of which were outstanding at March 31, 2021. The Company has the ability to borrow funds from the Federal Reserve Bank (“FRB”) of Atlanta utilizing the discount window. The discount window is an instrument of monetary policy that allows eligible institutions to borrow money from the FRB on a short-term basis to meet temporary liquidity shortages caused by internal or external disruptions. At March 31, 2021, the Company had borrowing capacity available under this arrangement, with no outstanding balances. The Company would be required to pledge certain available-for-sale investment securities as collateral under this agreement. The Company's Trust Preferred Securities are recorded as subordinated debentures on the consolidated balance sheets, but subject to certain limitations, qualify as Tier 1 Capital for regulatory capital purposes. At March 31, 2021 and December 31, 2020, Trust Preferred Securities was $24.2 million. The proceeds from the offerings were used to fund certain acquisitions, pay off holding company debt and inject capital into the bank subsidiary. The Trust preferred securities pay interest quarterly. |
Earnings Per Share
Earnings Per Share | 3 Months Ended |
Mar. 31, 2021 | |
Earnings Per Share [Abstract] | |
Earnings Per Share | Earnings Per Share Basic earnings per share is computed by dividing net income available to common stockholders by the weighted average number of common shares outstanding during each period. Diluted earnings per share reflects the potential dilution of restricted stock. The following table presents earnings per share for the three months ended March 31, 2021 and 2020. (dollars in thousands, except per share data) Three Months Ended 2021 2020 Numerator Net income available to common stockholders $ 4,919 $ 1,603 Denominator Weighted average number of common shares Outstanding for basic earnings per common share 9,499 9,499 Weighted-average number of shares outstanding for diluted earnings per common share 9,499 9,499 Earnings per share - basic $ 0.52 $ 0.17 Earnings per share - diluted $ 0.52 $ 0.17 |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Credit-Related Financial Instruments. The Company is a party to credit related financial instruments with off-balance sheet risk in the normal course of business to meet the financing needs of its customers. These financial instruments include commitments to extend credit, standby letters of credit and commercial letters of credit. Such commitments involve, to varying degrees, elements of credit and interest rate risk in excess of the amount recognized in the consolidated balance sheets. The Company’s exposure to credit loss is represented by the contractual amount of these commitments. The Company follows the same credit policies in making commitments as it does for on-balance sheet instruments. The Company evaluates each customer’s creditworthiness on a case-by-case basis. The amount of collateral obtained, if deemed necessary, upon extension of credit, is based on management’s credit evaluation of the borrower. Collateral held varies, but may include cash or cash equivalents, negotiable instruments, real estate, accounts receivable, inventory, oil, gas and mineral interests, property, plant, and equipment. At March 31, 2021 and December 31, 2020 the following financial instruments were outstanding whose contract amounts represent credit risk: Contract Amount (dollars in thousands) March 31, 2021 December 31, 2020 Loan commitments $ 235,074 $ 198,029 Letters of credit 4,342 3,634 Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the contract. Commitments generally have fixed expiration dates or other termination clauses and may require payment of a fee. The commitments for equity lines of credit may expire without being drawn upon. Therefore, the total commitment amounts do not necessarily represent future cash requirements. The amount of collateral obtained, if it is deemed necessary by the Company, is based on management’s credit evaluation of the customer. Unfunded commitments under commercial lines of credit, revolving credit lines and overdraft protection agreements are commitments for possible future extensions of credit to existing customers. These lines of credit are uncollateralized and usually do not contain a specified maturity date and may not be drawn upon to the total extent to which the Company is committed. Standby and performance letters of credit are conditional lending commitments issued by the Company to guarantee the performance of a customer to a third party. Those letters of credit are primarily issued to support public and private borrowing arrangements. Essentially all letters of credit issued have expiration dates within one year. The credit risk involved in issuing letters of credit is essentially the same as that involved in extending loan facilities to customers. Legal Contingencies . In the ordinary course of business, there are various legal proceedings pending against the Company and the Bank. As of March 31, 2021, the aggregate liabilities, if any, arising from such proceedings would not, in the opinion of management, have a material adverse effect on the Company’s consolidated financial position. |
Fair Value of Financial Instrum
Fair Value of Financial Instruments and Fair Value Measurements | 3 Months Ended |
Mar. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Fair Value of Financial Instruments and Fair Value Measurements | Fair Value of Financial Instruments and Fair Value Measurements Generally accepted accounting standards in the U.S. require disclosure of fair value information about financial instruments, whether or not recognized on the face of the balance sheet, for which it is practicable to estimate that value. The assumptions used in the estimation of the fair value of the Company and the Bank’s financial instruments are detailed hereafter. Where quoted prices are not available, fair values are based on estimates using discounted cash flows and other valuation techniques. The use of discounted cash flows can be significantly affected by the assumptions used, including the discount rate and estimates of future cash flows. Generally accepted accounting principles related to Fair Value Measurements define fair value, establish a framework for measuring fair value, establish a three-level valuation hierarchy for disclosure of fair value measurement and enhance disclosure requirements for fair value measurements. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. The three levels are defined as follows: • Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. • Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. • Level 3 inputs to the valuation methodology are unobservable and represent the Company’s own assumptions about the assumptions that market participants would use in pricing the assets or liabilities. The following disclosures should not be considered a surrogate of the liquidation value of the Company, but rather a good-faith estimate of the increase or decrease in value of financial instruments held by the Company since purchase, origination or issuance. Cash and short-term investments – For cash, due from banks, bank-owned deposits and federal funds sold, the carrying amount is a reasonable estimate of fair value and is classified as Level 1. Investment securities – Fair values for investment securities are based on quoted market prices where available and classified as Level 1. If quoted market prices are not available, estimated fair values are based on quoted market prices of comparable instruments and classified as Level 2. If a comparable is not available, the investment securities are classified as Level 3. Other investments, at cost – The fair value of Federal Home Loan Bank stock approximates carrying value and is classified as Level 1. If quoted market prices are not available, estimated fair values are based on quoted market prices of comparable instruments and classified as Level 2. Loans held for sale – The fair value of loans held for sale is determined on outstanding commitments from third party investors in the secondary markets and is classified within Level 2 of the valuation hierarchy. Loans – The fair value of fixed rate loans is estimated by discounting the future cash flows using the current rates at which similar loans would be made to borrowers with similar credit ratings. For variable rate loans, the carrying amount is a reasonable estimate of fair value. Most loans are classified as Level 3. Deposit liabilities – The fair value of demand deposits, savings accounts and certain money market deposits is the amount payable on demand at the reporting date and is classified as Level 2. The fair value of deposits is estimated by discounting the future cash flows using the rates currently offered for deposits of similar remaining maturities and is classified as Level 2. Federal Home Loan Bank advances – The fair value of Federal Home Loan Bank advances is estimated by discounting the future cash flows using the current rates at which similar advances would be obtained. Federal Home Loan Bank advances are classified as Level 2. Paycheck Protection Liquidity Facility – The fair value of Paycheck Protection Liquidity Facility is estimated by discounting the future cash flows using the current rates at which similar advances would be obtained. Paycheck Protection Liquidity Facility are classified as Level 2. Other borrowings – The fair value of other borrowings is calculated by discounting contractual cash flows using an estimated interest rate based on current rates available to the Company for debt of similar remaining maturities and collateral terms. Other borrowings is classified as Level 2 due to their expected maturities. Disclosures of the fair value of financial assets and financial liabilities, including those financial assets and financial liabilities that are not measured and reported at fair value on a recurring basis or non-recurring basis, are required in the financial statements. The carrying amount, estimated fair values, and placement in the fair value hierarchy of the Company’s financial instruments as of March 31, 2021 and December 31, 2020 are as follows: Fair Value Measurements (dollars in thousands) Carrying Estimated Level Level Level March 31, 2021 Assets Cash and short-term investments $ 181,588 $ 181,588 $ 181,588 $ — $ — Investment securities available for sale 433,729 433,729 — 433,729 — Other investments, at cost 2,703 2,703 — 2,703 — Loans held for sale 28,429 28,429 — 28,429 — Loans, net 1,050,082 1,061,554 — — 1,061,554 Liabilities Deposits 1,525,884 1,526,740 — 1,526,740 — Paycheck Protection Program Liquidity Facility 60,602 60,602 — 60,602 — Federal Home Loan Bank advances 22,500 21,312 — 21,312 — Other borrowings 37,542 37,767 — 37,767 — Fair Value Measurements (dollars in thousands) Carrying Estimated Level Level Level December 31, 2020 Assets Cash and short-term investments $ 183,506 $ 183,506 $ 183,506 $ — $ — Investment securities available for sale 380,814 380,814 245 380,569 — Other investments, at cost 3,296 3,296 — 3,296 — Loans held for sale 52,386 52,386 — 52,386 — Loans, net 1,047,376 1,063,785 — — 1,063,785 Liabilities Deposits 1,445,027 1,445,984 — 1,445,984 — Paycheck Protection Program Liquidity Facility 106,789 106,789 — 106,789 Federal Home Loan Bank advances 22,500 20,817 — 20,817 — Other borrowings 37,792 37,792 — 37,792 — Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial instrument. These estimates do not reflect any premium or discount that could result from offering for sale at one time the Company’s entire holdings of a particular financial instrument. Because no market exists for a significant portion of the Company’s financial instruments, fair value estimates are based on many judgments. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates. Fair value estimates are based on existing on and off-balance sheet financial instruments without attempting to estimate the value of anticipated future business and the value of assets and liabilities that are not considered financial instruments. Significant assets and liabilities that are not considered financial instruments include deferred income taxes and premises and equipment. In addition, the tax ramifications related to the realization of the unrealized gains and losses can have a significant effect on fair value estimates and have not been considered in the estimates. Following is a description of the valuation methodologies used for instruments measured at fair value on a recurring and nonrecurring basis, as well as the general classification of such instruments pursuant to the valuation hierarchy: Securities – Where quoted prices are available in an active market, securities are classified within level 1 of the valuation hierarchy. Level 1 inputs include securities that have quoted prices in active markets for identical assets. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics, or discounted cash flow. Examples of such instruments, which would generally be classified within level 2 of the valuation hierarchy, include certain collateralized mortgage and debt obligations and certain high-yield debt securities. In certain cases where there is limited activity or less transparency around inputs to the valuation, securities are classified within level 3 of the valuation hierarchy. When measuring fair value, the valuation techniques available under the market approach, income approach and/or cost approach are used. The Company’s evaluations are based on market data and the Company employs combinations of these approaches for its valuation methods depending on the asset class. Impaired Loans – Impaired loans are those loans which the Company has measured impairment generally based on the fair value of the loan’s collateral. Fair value is generally determined based upon independent third-party appraisals of the properties, or discounted cash flows based upon the expected proceeds. These assets are included as Level 3 fair values, based upon the lowest level of input that is significant to the fair value measurements. Other Real Estate Owned – Other real estate owned assets are adjusted to fair value less estimated selling costs upon transfer of the loans to other real estate owned. Typically, an external, third-party appraisal is performed on the collateral upon transfer into the other real estate owned account to determine the asset’s fair value. Subsequent adjustments to the collateral’s value may be based upon either updated third-party appraisals or management’s knowledge of the collateral and the current real estate market conditions. Appraised amounts used in determining the asset’s fair value, whether internally or externally prepared, are discounted 10% to account for selling and marketing costs. Adjustments are routinely made in the appraisal process by the appraisers to adjust for differences between the comparable sales and income data available. Such adjustments are typically significant and result in a level 3 classification of the inputs for determining fair value. Because of the high degree of judgment required in estimating the fair value of other real estate owned assets and because of the relationship between fair value and general economic conditions, we consider the fair value of other real estate owned assets to be highly sensitive to changes in market conditions. Assets Measured at Fair Value on a Recurring and Nonrecurring Basis – The following table presents the recorded amount of the Company’s assets measured at fair value on a recurring and nonrecurring basis as of March 31, 2021 and December 31, 2020, aggregated by the level in the fair value hierarchy within which those measurements fall. The table below includes only impaired loans with a specific reserve and only other real estate properties with a valuation allowance at March 31, 2021 and December 31, 2020. Those impaired loans and other real estate properties are shown net of the related specific reserves and valuation allowances. Fair Value Measurements at Reporting Date Using (dollars in thousands) Total Fair Value (Level 1) (Level 2) (Level 3) March 31, 2021 Nonrecurring Collateral dependent impaired loans $ 4,984 $ — $ — $ 4,984 Other real estate owned 518 — — 518 Total nonrecurring assets $ 5,502 $ — $ — $ 5,502 Fair Value Measurements at Reporting Date Using (dollars in thousands) Total Fair (Level 1) (Level 2) (Level 3) December 31, 2020 Nonrecurring Collateral dependent impaired loans $ 5,939 $ — $ — 5,939 Other real estate owned 1,006 — — 1,006 Total nonrecurring assets $ 6,945 $ — $ — $ 6,945 Fair Value Measurements Using Significant Unobservable Inputs (Level 3) The following table presents quantitative information about the significant unobservable inputs used in the fair value measurements for assets in level 3 of the fair value hierarchy measured on a nonrecurring basis at March 31, 2021 and December 31, 2020. This table is comprised primarily of collateral dependent impaired loans and other real estate owned: (dollars in thousands) March 31, 2021 Valuation Unobservable Range Collateral dependent impaired loans $ 4,984 Appraised Value Discounts to reflect current market conditions, ultimate collectability, and estimated costs to sell 25 % 100 % Other real estate owned 518 Appraised Value/Comparable Sales Discounts to reflect current market conditions and estimated costs to sell — % 20 % (dollars in thousands) December 31, 2020 Valuation Unobservable Range Collateral dependent impaired loans $ 5,939 Appraised Value Discounts to reflect current market conditions, ultimate collectability, and estimated costs to sell 25 % 100 % Other real estate owned 1,006 Appraised Value/Comparable Sales Discounts to reflect current market conditions and estimated costs to sell — % 20 % The table below presents a reconciliation and statement of income classification of gains and losses for all assets measured at fair value on a recurring basis using significant unobservable inputs (level 3) for the three months ended March 31, 2020. Available for Sale Securities (dollars in thousands) March 31, 2020 Balance, Beginning $ 2,022 Transfers out of Level 3 — Sales — Paydowns (5) Realized Loss on Sale of Security — Unrealized gains (losses) included in Other Comprehensive Income — Balance, Ending $ 2,017 The Company’s policy is to recognize transfers in and transfers out of levels 1, 2 and 3 as of the end of a reporting period. There were no transfers of securities between levels for the three months ended March 31, 2020. |
Segment Information
Segment Information | 3 Months Ended |
Mar. 31, 2021 | |
Segment Reporting [Abstract] | |
Segment Information | Segment Information The Company’s operating segments include banking, mortgage banking and small business specialty lending division. The reportable segments are determined by the products and services offered, and internal reporting. The Bank segment derives its revenues from the delivery of full-service financial services, including retail and commercial banking services and deposit accounts. The Mortgage Banking segment derives its revenues from the origination and sales of residential mortgage loans held for sale. The Small Business Specialty Lending Division segment derives its revenue from the origination, sales and servicing of Small Business Administration loans and other government guaranteed loans. Segment performance is evaluated using net interest income and noninterest income. Income taxes are allocated based on income before income taxes, and indirect expenses (includes management fees) are allocated based on various internal factors for each segment. Transactions among segments are made at fair value. Information reported internally for performance assessment follows. The following tables present information reported internally for performance assessment for the three months ended March 31, 2021 and 2020: (dollars in thousands) Bank Mortgage Small Totals Three months ended March 31, 2021 Net Interest Income $ 13,985 $ 168 $ 130 $ 14,283 Provision for Loan Losses 500 — — 500 Noninterest Income 3,005 3,986 1,585 8,576 Noninterest Expenses 11,960 2,793 1,029 15,782 Income Taxes 1,160 354 144 1,658 Segment Profit (Loss) $ 3,370 $ 1,007 $ 542 $ 4,919 Segments Assets at March 31, 2021 $ 1,755,667 $ 27,478 $ 15,901 $ 1,799,046 Full time employees at March 31, 2021 291 51 23 365 (dollars in thousands) Bank Mortgage Small Totals Three months ended March 31, 2020 Net Interest Income $ 12,656 $ 34 $ 14 $ 12,704 Provision for Loan Losses 1,956 — — 1,956 Noninterest Income 3,014 1,253 259 4,526 Noninterest Expenses 11,632 1,195 516 13,343 Income Taxes 368 11 (51) 328 Segment Profit $ 1,714 $ 81 $ (465) $ 1,603 Segments Assets at December 31, 2020 $ 1,709,696 $ 50,266 $ 4,012 $ 1,763,974 Full time employees at March 31, 2020 319 34 12 365 |
Regulatory Capital Matters
Regulatory Capital Matters | 3 Months Ended |
Mar. 31, 2021 | |
Banking And Thrift Disclosure [Abstract] | |
Regulatory Capital Matters | Regulatory Capital Matters The amount of dividends payable to the parent company from the subsidiary bank is limited by various banking regulatory agencies. Upon approval by regulatory authorities, the Bank may pay cash dividends to the parent company in excess of regulatory limitations. The Company is subject to various regulatory capital requirements administered by federal banking agencies. Failure to meet minimum capital requirements can initiate certain mandatory and, possibly, additional discretionary actions by regulators that, if undertaken, could have a direct material effect on the Company’s consolidated financial statements. Under capital adequacy guidelines and the regulatory framework for prompt corrective action, the Company must meet specific capital guidelines that involve quantitative measures of the Company’s assets, liabilities and certain off-balance sheet items as calculated under regulatory accounting practices. The Company’s capital amounts and classifications are also subject to qualitative judgments by the regulators about components, risk weightings and other factors. Quantitative measures established by regulation to ensure capital adequacy require the Company to maintain minimum amounts and ratios of total and Tier 1 capital to risk-weighted assets, and of Tier 1 capital to average assets. As of March 31, 2021, the interim final Basel III rules (“Basel III”) require the Company to also maintain minimum amounts and ratios of common equity Tier 1 capital to risk-weighted assets. These amounts and ratios as defined in regulations are presented hereafter. Management believes, as of March 31, 2021, the Company meets all capital adequacy requirements to which it is subject under the regulatory framework for prompt corrective action. In the opinion of management, there are no events or conditions since prior notification of capital adequacy from the regulators that have changed the institution’s category. The Basel III rules also require the implementation of a new capital conservation buffer comprised of common equity Tier 1 capital. The capital conservation buffer was phased in beginning January 1, 2016 at 0.625% of risk-weighted assets and increase each subsequent year by 0.625% until reaching its final level of 2.5% on January 1, 2019. The Bank is participating in the PPP and the PPPLF to fund PPP Loans. In accordance with regulatory guidance, PPP loans pledged as collateral for PPPLF, and PPPLF advances, are excluded from leverage capital ratios. PPP loans will also carry a 0% risk-weight for risk-based capital rules. The Board of Governors of the Federal Reserve raised the threshold for determining applicable of the Small Bank Holding Company and Savings and Loan Company Policy Statement in August 2018 from $1 billion to $3 billion in consolidated total assets to provide regulatory burden relief, therefore, the Company is no longer subject to the minimum capital requirements. The following table summarizes regulatory capital information as of March 31, 2021 and December 31, 2020 on a consolidated basis and for the subsidiary, as defined. Regulatory capital ratios for March 31, 2021 and December 31, 2020 were calculated in accordance with the Basel III rules. (dollars in thousands) Actual For Capital To Be Well Amount Ratio Amount Ratio Amount Ratio As of March 31, 2021 Total Capital to Risk-Weighted Assets Consolidated $ 159,767 13.76 % $ 92,888 8.00 % N/A N/A Colony Bank 163,639 13.81 94,794 8.00 $ 118,493 10.00 % Tier I Capital to Risk-Weighted Assets Consolidated 147,074 12.49 70,652 6.00 N/A N/A Colony Bank 150,946 12.74 71,089 6.00 94,786 8.00 Common Equity Tier I Capital to Risk-Weighted Assets Consolidated 123,574 10.49 53,011 4.50 N/A N/A Colony Bank 150,946 12.74 53,317 4.50 77,013 6.50 Tier I Capital to Average Assets Consolidated 147,074 8.70 67,620 4.00 N/A N/A Colony Bank 150,946 9.05 66,716 4.00 83,396 5.00 (dollars in thousands) Actual For Capital To Be Well Amount Ratio Amount Ratio Amount Ratio As of December 31, 2020 Total Capital to Risk-Weighted Assets Consolidated $ 155,447 13.78 % $ 90,245 8.00 % N/A N/A Colony Bank 164,050 14.55 90,199 8.00 $ 112,749 10.00 % Tier I Capital to Risk-Weighted Assets Consolidated 143,320 12.71 67,657 6.00 N/A N/A Colony Bank 151,923 13.48 67,622 6.00 90,162 8.00 Common Equity Tier I Capital to Risk-Weighted Assets Consolidated 119,820 10.62 50,771 4.50 N/A N/A Colony Bank 151,923 13.48 50,716 4.50 73,257 6.50 Tier I Capital to Average Assets Consolidated 143,320 8.49 67,524 4.00 N/A N/A Colony Bank 151,923 9.12 66,633 4.00 83,291 5.00 |
Subsequent Events
Subsequent Events | 3 Months Ended |
Mar. 31, 2021 | |
Subsequent Events [Abstract] | |
Subsequent Events | Subsequent Events Merger Announcement Colony Bankcorp, Inc, and SouthCrest Financial Group, Inc. (PK: SCSG) ("SouthCrest"), the holding company for SouthCrest Bank, N.A., on April 22, 2021 jointly announced the signing of an Agreement and Plan of Merger under which Colony has agreed to acquire 100% of the common stock of SouthCrest in a combined stock-and-cash transaction valued at approximately $84.0 million. Upon completion of the transaction, Colony is expected to have approximately $2.4 billion in assets, $1.4 billion in loans, $2.0 billion in deposits, and $165.8 million in tangible common equity. The transaction is expected to be meaningfully accretive to Colony's fully diluted earnings per share in year one, excluding transaction costs. The Agreement and Plan of Merger has been approved by the Boards of Directors of Colony and SouthCrest. The closing of the transaction, which is expected to occur no later than the fourth quarter of 2021, is subject to customary conditions, including regulatory approval and approval by the shareholders of Colony and SouthCrest. Under the terms of the Agreement and Plan of Merger, each SouthCrest shareholder will have the right to elect to receive either $10.45 in cash or 0.7318 shares of Colony's common stock in exchange for each share of SouthCrest common or preferred stock, subject to customary proration and allocation procedures such that approximately 27.5% of SouthCrest shares will be converted to cash consideration and the remaining 72.5% of SouthCrest shares will be converted to Colony common stock. Based on Colony’s closing stock price of $15.00 per share as of April 21, 2021, the value of the per share merger consideration is estimated to be $10.83. Dividend On April 22, 2021, the Board of Directors declared a quarterly cash dividend of $0.1025 per share, to be paid on its common stock on May 17, 2021, to shareholders of record as of the close of business on May 3, 2021. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2021 | |
Accounting Policies [Abstract] | |
Presentation | Presentation Colony Bankcorp, Inc. (the “Company”) is a bank holding company located in Fitzgerald, Georgia. The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Colony Bank, Fitzgerald, Georgia (the “Bank”). The “Company” or “our,” as used herein, includes Colony Bank, except where the content requires otherwise. In July 2019, a new subsidiary of the Company was incorporated under the name Colony Risk Management, Inc. Colony Risk Management, Inc. is a subsidiary of the Company and is located in Las Vegas, Nevada. It is a captive insurance subsidiary which insures various liability and property damage policies for the Company and its related subsidiaries. Colony Risk Management is regulated by the State of Nevada Division of Insurance. All adjustments consisting of normal recurring accruals which are, in the opinion of management, necessary for fair presentation of the interim consolidated financial statements, have been included and fairly and accurately present the financial position, results of operations and cash flows of the Company. All significant intercompany accounts have been eliminated in consolidation. The accounting and reporting policies of the Company conform to generally accepted accounting principles and practices utilized in the commercial banking industry for interim financial information and Regulation S-X. Accordingly, the accompanying unaudited interim consolidated financial statements do not include all of the information or notes required for complete financial statements. The results of operations for the three months ended March 31, 2021 are not necessarily indicative of the results which may be expected for the year ending December 31, 2021. These statements should be read in conjunction with the consolidated financial statements and notes thereto in the Company's Annual Report on Form 10-K for the year ended December 31, 2020 (“2020 10-K”). |
Nature of Operations | Nature of Operations The Bank provides a full range of retail, commercial and mortgage banking services for consumers and small- to medium-size businesses located primarily in central, south and coastal Georgia. The Bank is headquartered in Fitzgerald, Georgia with banking and mortgage offices in Albany, Ashburn, Athens, Broxton, Centerville, Columbus, Cordele, Douglas, Eastman, Fitzgerald, LaGrange, Leesburg, Macon, Moultrie, Quitman, Rochelle, Savannah, Soperton, Sylvester, Statesboro, Tifton, Valdosta and Warner Robins. Lending and investing activities are funded primarily by deposits gathered through its retail banking office network. |
Use of Estimates | Use of Estimates In preparing the consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the balance sheet date and revenues and expenses for the period. Actual results could differ significantly from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the determination of the allowance for loan losses, the valuation of real estate acquired in connection with foreclosures or in satisfaction of loans and fair value of assets acquired and liabilities assumed in a business combination, including goodwill impairment. |
Reclassifications | Reclassifications In certain instances, amounts reported in prior years’ consolidated financial statements have been reclassified to conform to statement presentations selected for 2021. Such reclassifications have not materially affected previously reported stockholders’ equity or net income. |
Concentrations of Credit Risk | Concentrations of Credit Risk Concentrations of credit risk can exist in relation to individual borrowers or groups of borrowers, certain types of collateral, certain types of industries, or certain geographic regions. The Company has a concentration in real estate loans as well as a geographic concentration that could pose an adverse credit risk. At March 31, 2021, approximately 78% of the Company’s loan portfolio was concentrated in loans secured by real estate. A substantial portion of borrowers’ ability to honor their contractual obligations is dependent upon the viability of the real estate economic sector. Management continues to monitor these concentrations and has considered these concentrations in its allowance for loan loss analysis. The success of the Company is dependent, to a certain extent, upon the economic conditions in the geographic markets it serves. Adverse changes in the economic conditions in these geographic markets would likely have a material adverse effect on the Company’s results of operations and financial condition. The operating results of the Company depend primarily on its net interest income. Accordingly, operations are subject to risks and uncertainties surrounding the exposure to changes in the interest rate environment. At times, the Company may have cash and cash equivalents at financial institutions in excess of federal deposit insurance limits. The Company places its cash and cash equivalents with high credit quality financial institutions whose credit ratings are monitored by management to minimize credit risk. |
Changes in Accounting Principles and effects of New Accounting Pronouncements | Changes in Accounting Principles and Effects of New Accounting Pronouncements ASU 2016-13, Financial Instruments – Credit Losses (Topic 326). This ASU sets forth a “current expected credit loss” (CECL) model which requires the Company to measure all expected credit losses for financial instruments held at the reporting date based on historical experience, current conditions and reasonable supported forecasts. This replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost and applies to some off-balance sheet credit exposures. This ASU is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. On October 16, 2019, the Financial Accounting Standards Board ("FASB") voted to extend the delay of the effective date of this ASU for smaller reporting companies, such as the Company, until fiscal years beginning after December 15, 2022. The Company is currently assessing the impact of the adoption of this ASU on its consolidated financial statements. In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740) : Simplifying the Accounting for Income Taxes. This update removes several exceptions related to intraperiod tax allocation when there is a loss from continuing operations and income from other items, foreign subsidiaries becoming equity method investments and vice versa, and calculating income taxes in an interim period when a year-to-date loss exceeds the anticipated loss for the year. The guidance also amends requirements related to franchise tax that is partially based on income, a step up in the tax basis of goodwill, allocation of consolidated tax expense to a legal entity not subject to tax in its separate financial statements, the effects of enacted changes in tax laws and other minor codification improvements regarding employee stock ownership plans and investments in qualified affordable housing projects. For public entities, this guidance is effective for fiscal years beginning after December 15, 2020. The adoption of this standard did not have a material impact on the consolidated financial statements. In January 2020, the FASB issued ASU No. 2020-01, Investments—Equity Securities (Topic 321), Investments—Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)—Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force) . This update clarifies whether an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative and how to account for certain forward contracts and purchased options to purchase securities. For public entities, this guidance is effective for fiscal years beginning after December 15, 2020. The adoption of this standard did not have a material impact on the consolidated financial statements. In March 2020, the FASB issued ASU No. 2020-04, Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting ("ASU 2020-04"). ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March 12, 2020 through December 31, 2022. The adoption of this standard did not have a material impact on the consolidated financial statements. Operating, Accounting and Reporting Considerations Related to COVID-19 The COVID-19 pandemic has negatively impacted the global economy, including the Company’s primary metropolitan markets. In response to this crisis, the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act was passed by Congress and signed into law on March 27, 2020. The CARES Act provides an estimated $2.2 trillion to fight the COVID-19 pandemic and stimulate the economy by supporting individuals and businesses through loans, grants, tax changes, and other types of relief. Some of the provisions applicable to the Company include, but are not limited to: • Accounting for Loan Modifications - The CARES Act provides that financial institutions may elect to suspend (1) the requirements under GAAP for certain loan modifications that would otherwise by categorized as a troubled debt restructure (“TDR”) and (2) any determination that such loan modifications would be considered a TDR, including the related impairment for accounting purposes. • Paycheck Protection Program - The CARES Act established the Paycheck Protection Program (“PPP”), an expansion of the Small Business Administration’s 7(a) loan program and the Economic Injury Disaster Loan Program (“EIDL”), administered directly by the SBA. Also in response to the COVID-19 pandemic, the Board of Governors of the Federal Reserve System (“FRB”), the Federal Deposit Insurance Corporation (“FDIC”), the National Credit Union Administration (“NCUA”), the Office of the Comptroller of the Currency (“OCC”), and the Consumer Financial Protection Bureau (“CFPB”), in consultation with the state financial regulators (collectively, the “agencies”) issued a joint interagency statement (issued March 22, 2020; revised statement issued April 7, 2020). Some of the provisions applicable to the Company include, but are not limited to: • Accounting for Loan Modifications - Loan modifications that do not meet the conditions of the CARES Act may still qualify as a modification that does not need to be accounted for as a TDR. The agencies confirmed with FASB staff that short-term modifications made on a good faith basis in response to COVID-19 to borrowers who were current prior to any relief are not TDRs. This includes short-term (e.g., three months) modifications such as payment deferrals, fee waivers, extensions of repayment terms, or insignificant delays in payment, as long as such modifications are (1) related to COVID-19; (2) executed on a loan that was not more than 30 days past due as of December 31, 2019; and (3) executed between March 1, 2020, and the earlier of (a) 60 days after the date of termination of the national emergency declaration or (b) December 31, 2020. • Past Due Reporting - With regard to loans not otherwise reportable as past due, financial institutions are not expected to designate loans with deferrals granted due to COVID-19 as past due because of the deferral. A loan’s payment date is governed by the due date stipulated in the legal agreement. If a financial institution agrees to a payment deferral, these loans would not be considered past due reporting during the period of the deferral. • Nonaccrual Status and Charge-offs - During short-term COVID-19 modifications, these loans generally should not be reported as nonaccrual or as classified. As such, beginning in late March 2020, the Company provided relief programs consisting primarily of 90-day payment deferral relief of principal and interest to borrowers negatively impacted by COVID-19 and has accounted for these loan modifications in accordance with ASC 310-40. In addition, the Company also provided principal only payment deferral relief to borrowers of which interest income has been recognized during the deferment period on these interest-only loans. |
Earnings Per Share | Basic earnings per share is computed by dividing net income available to common stockholders by the weighted average number of common shares outstanding during each period. Diluted earnings per share reflects the potential dilution of restricted stock. |
Fair Value of Financial Instruments and Fair Value Measurements | Cash and short-term investments – For cash, due from banks, bank-owned deposits and federal funds sold, the carrying amount is a reasonable estimate of fair value and is classified as Level 1. Investment securities – Fair values for investment securities are based on quoted market prices where available and classified as Level 1. If quoted market prices are not available, estimated fair values are based on quoted market prices of comparable instruments and classified as Level 2. If a comparable is not available, the investment securities are classified as Level 3. Other investments, at cost – The fair value of Federal Home Loan Bank stock approximates carrying value and is classified as Level 1. If quoted market prices are not available, estimated fair values are based on quoted market prices of comparable instruments and classified as Level 2. Loans held for sale – The fair value of loans held for sale is determined on outstanding commitments from third party investors in the secondary markets and is classified within Level 2 of the valuation hierarchy. Loans – The fair value of fixed rate loans is estimated by discounting the future cash flows using the current rates at which similar loans would be made to borrowers with similar credit ratings. For variable rate loans, the carrying amount is a reasonable estimate of fair value. Most loans are classified as Level 3. Deposit liabilities – The fair value of demand deposits, savings accounts and certain money market deposits is the amount payable on demand at the reporting date and is classified as Level 2. The fair value of deposits is estimated by discounting the future cash flows using the rates currently offered for deposits of similar remaining maturities and is classified as Level 2. Federal Home Loan Bank advances – The fair value of Federal Home Loan Bank advances is estimated by discounting the future cash flows using the current rates at which similar advances would be obtained. Federal Home Loan Bank advances are classified as Level 2. Paycheck Protection Liquidity Facility – The fair value of Paycheck Protection Liquidity Facility is estimated by discounting the future cash flows using the current rates at which similar advances would be obtained. Paycheck Protection Liquidity Facility are classified as Level 2. Other borrowings – The fair value of other borrowings is calculated by discounting contractual cash flows using an estimated interest rate based on current rates available to the Company for debt of similar remaining maturities and collateral terms. Other borrowings is classified as Level 2 due to their expected maturities. |
Investment Securities (Tables)
Investment Securities (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Investments, Debt and Equity Securities [Abstract] | |
Marketable Securities | The amortized cost and estimated fair value of securities available for sale along with gross unrealized gains and losses are summarized as follows: (dollars in thousands) March 31, 2021 Amortized Gross Gross Fair Value Securities Available for Sale: U.S. treasury securities $ 245 $ — $ — $ 245 U.S. agency 9,863 11 (70) 9,804 Mutual fund 3,998 — — 3,998 State, county & municipal securities 73,041 356 (1,073) 72,324 Corporate debt securities 5,250 1 (22) 5,229 Mortgage-backed securities 338,990 5,514 (2,375) 342,129 $ 431,387 $ 5,882 $ (3,540) $ 433,729 December 31, 2020 Securities Available for Sale: U.S. treasury securities $ 245 $ — $ — $ 245 U.S. agency 1,000 4 — 1,004 State, county & municipal securities 61,298 1,155 (65) 62,388 Corporate debt securities 4,250 1 (1) 4,250 Mortgage-backed securities 305,438 7,837 (348) 312,927 $ 372,231 $ 8,997 $ (414) $ 380,814 |
Investments Classified by Contractual Maturity Date | This is often the case with mortgage-backed securities, which are disclosed separately in the table below. Securities Available for Sale (dollars in thousands) Amortized Cost Fair Value Due in one year or less $ 6,243 $ 6,244 Due after one year through five years 1,910 1,948 Due after five years through ten years 33,362 33,152 Due after ten years 50,882 50,256 $ 92,397 $ 91,600 Mortgage-backed securities 338,990 342,129 $ 431,387 $ 433,729 |
Schedule of Unrealized Loss on Investments | Information pertaining to securities with gross unrealized losses at March 31, 2021 and December 31, 2020 aggregated by investment category and length of time that individual securities have been in a continuous loss position, follows: Less Than 12 Months 12 Months or Greater Total (dollars in thousands) Fair Gross Fair Gross Fair Gross March 31, 2021 U.S. agency $ 8,662 $ (70) $ — $ — $ 8,662 $ (70) State, county & municipal securities 47,942 (1,073) — — 47,942 (1,073) Corporate debt securities 1,728 (22) — — 1,728 (22) Mortgage-backed securities 120,777 (2,159) 4,005 (216) 124,782 (2,375) $ 170,447 $ (3,254) $ 4,005 $ (216) $ 174,452 $ (3,470) December 31, 2020 State, county & municipal securities $ 8,282 $ (65) $ — $ — $ 8,282 $ (65) Corporate debt securities 999 (1) — — 999 (1) Mortgage-backed securities 28,835 (77) 3,949 (271) 32,784 (348) $ 38,116 $ (143) $ 3,949 $ (271) $ 42,065 $ (414) |
Loans (Tables)
Loans (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Receivables [Abstract] | |
Schedule of Accounts, Notes, Loans and Financing Receivable | The following table presents the composition of loans segregated by legacy and purchased loans and by class of loans, as of March 31, 2021 and December 31, 2020. Purchased loans are defined as loans that were acquired in bank acquisitions. March 31, 2021 (dollars in thousands) Legacy Loans Purchased Loans Total Construction, land and land development $ 109,585 $ 6,383 $ 115,967 Other commercial real estate 499,604 38,477 538,080 Total commercial real estate 609,189 44,860 654,047 Residential real estate 165,887 12,324 178,211 Commercial, financial, & agricultural (*) 199,862 10,452 210,315 Consumer and other 18,055 2,147 20,202 Total Loans $ 992,993 $ 69,783 $ 1,062,775 December 31, 2020 (dollars in thousands) Legacy Loans Purchased Loans Total Construction, land and land development $ 109,577 $ 11,516 $ 121,093 Other commercial real estate 477,445 42,946 520,391 Total commercial real estate 587,022 54,462 641,484 Residential real estate 167,714 15,307 183,021 Commercial, financial, & agricultural (*) 200,800 12,580 213,380 Consumer and other 19,037 2,581 21,618 Total Loans $ 974,573 $ 84,930 $ 1,059,503 (*) Includes $102.6 million and $101.1 million in PPP loans at March 31, 2021 and December 31, 2020 |
Financing Receivable Credit Quality Indicators | The following table presents the loan portfolio, excluding purchased loans, by credit quality indicator (risk grade) as of March 31, 2021 and December 31, 2020. Those loans with a risk grade of 1, 2, 3 or 4 have been combined in the pass column for presentation purposes. (dollars in thousands) Pass Special Mention Substandard Total Loans March 31, 2021 Construction, land and land development $ 98,634 $ 3,244 $ 7,707 $ 109,585 Other commercial real estate 452,356 30,301 16,946 499,604 Total commercial real estate 550,990 33,545 24,653 609,189 Residential real estate 156,665 3,090 6,132 165,887 Commercial, financial, & agricultural 196,052 2,795 1,015 199,862 Consumer and other 17,762 129 164 18,055 Total Loans $ 921,469 $ 39,559 $ 31,964 $ 992,993 (dollars in thousands) December 31, 2020 Construction, land and land development $ 99,430 $ 2,940 $ 7,207 $ 109,577 Other commercial real estate 430,515 33,579 13,351 477,445 Total commercial real estate 529,945 36,519 20,558 587,022 Residential real estate 157,927 3,855 5,932 167,714 Commercial, financial, & agricultural 196,749 2,870 1,181 200,800 Consumer and other 18,734 124 179 19,037 Total Loans $ 903,355 $ 43,368 $ 27,850 $ 974,573 December 31, 2020 The following table presents the purchased loan portfolio by credit quality indicator (risk grade) as of March 31, 2021 and December 31, 2020. Those loans with a risk grade of 1, 2, 3 or 4 have been combined in the pass column for presentation purposes. For the period ending March 31, 2021, the Company did not have any loans classified as “doubtful” or a “loss”. (dollars in thousands) Pass Special Mention Substandard Total Loans March 31, 2021 Construction, land and land development $ 6,263 $ 120 $ — $ 6,383 Other commercial real estate 32,391 3,423 2,663 38,477 Total commercial real estate 38,654 3,543 2,663 44,860 Residential real estate 11,944 301 78 12,324 Commercial, financial, & agricultural 8,283 1,690 480 10,452 Consumer and other 2,143 4 — 2,147 Total Loans $ 61,024 $ 5,538 $ 3,221 $ 69,783 December 31, 2020 Construction, land and land development $ 11,275 $ 241 $ — $ 11,516 Other commercial real estate 40,825 53 2,068 42,946 Total commercial real estate 52,100 294 2,068 54,462 Residential real estate 14,909 312 86 15,307 Commercial, financial, & agricultural 10,198 1,803 579 12,580 Consumer and other 2,364 25 192 2,581 Total Loans $ 79,571 $ 2,434 $ 2,925 $ 84,930 |
Financing Receivable, Past Due | The following table presents the aging of the amortized cost basis in legacy loans by aging category and accrual status as of March 31, 2021 and December 31, 2020: (dollars in thousands) 30-89 Days 90 Days Total Accruing Nonaccrual Current Loans Total Loans March 31, 2021 Construction, land and land development $ 24 $ — $ 24 $ 74 $ 109,487 $ 109,585 Other commercial real estate 108 — 108 5,154 494,342 499,604 Total commercial real estate 132 — 132 5,228 603,829 609,189 Residential real estate 471 — 471 2,572 162,844 165,887 Commercial, financial, & agricultural 149 — 149 810 198,903 199,862 Consumer and other 37 — 37 88 17,930 18,055 Total Loans $ 789 $ — $ 789 $ 8,698 $ 983,506 $ 992,993 December 31, 2020 Construction, land and land development $ 1,314 $ — $ 1,314 $ 80 $ 108,183 $ 109,577 Other commercial real estate 229 — 229 2,545 474,671 477,445 Total commercial real estate 1,543 — 1,543 2,625 582,854 587,022 Residential real estate 667 — 667 2,873 164,174 167,714 Commercial, financial, & agricultural 150 — 150 1,010 199,640 200,800 Consumer and other 48 — 48 102 18,887 19,037 Total Loans $ 2,408 $ — $ 2,408 $ 6,610 $ 965,555 $ 974,573 The following table presents the aging of the amortized cost basis in purchased loans by aging category and accrual status as of March 31, 2021 and December 31, 2020: (dollars in thousands) 30-89 Days 90 Days Total Accruing Nonaccrual Current Loans Total Loans March 31, 2021 Construction, land and land development $ — $ — $ — $ — $ 6,383 $ 6,383 Other commercial real estate — — — 1,883 36,594 38,477 Total commercial real estate — — — 1,883 42,977 44,860 Residential real estate 17 — 17 69 12,238 12,324 Commercial, financial, & agricultural 27 — 27 27 10,398 10,452 Consumer and other — — — — 2,147 2,147 Total Loans $ 44 $ — $ 44 $ 1,979 $ 67,760 $ 69,783 December 31, 2020 Construction, land and land development $ — $ — $ — $ 117 $ 11,399 $ 11,516 Other commercial real estate 544 — 544 2,068 40,334 42,946 Total commercial real estate 544 — 544 2,185 51,733 54,462 Residential real estate 15 — 15 85 15,207 15,307 Commercial, financial, & agricultural 125 — 125 55 12,400 12,580 Consumer and other — — — 193 2,388 2,581 Total Loans $ 684 $ — $ 684 $ 2,518 $ 81,728 $ 84,930 |
Impaired Financing Receivables | The following table details impaired loan data, including purchased credit impaired loans, as of March 31, 2021. March 31, 2021 (dollars in thousands) Unpaid Recorded Investment Related Average With No Related Allowance Recorded Construction, land and land development $ 7,480 $ 7,480 $ — $ 7,231 Commercial real estate 10,979 10,121 — 11,042 Residential real estate 1,047 1,067 — 1,084 Commercial, financial & agriculture 3 3 — 21 Consumer & other — — — — 19,509 18,671 — 19,378 With An Allowance Recorded Construction, land and land development — — — — Commercial real estate 5,242 5,247 1,315 5,783 Residential real estate 1,177 1,233 229 1,203 Commercial, financial & agriculture 86 86 38 198 Consumer & other 6 6 6 3 6,511 6,572 1,588 7,187 Purchased Credit Impaired Loans Construction, land and land development 116 48 38 71 Commercial real estate 780 764 42 382 Residential real estate 13 1 10 6 Commercial, financial & agriculture 247 27 100 37 Consumer & other — — — 48 1,156 840 190 544 Total Construction, land and land development 7,596 7,528 38 7,302 Commercial real estate 17,001 16,132 1,357 17,207 Residential real estate 2,237 2,301 239 2,293 Commercial, financial & agriculture 336 116 138 256 Consumer & other 6 6 6 51 $ 27,176 $ 26,083 $ 1,778 $ 27,109 The following table details impaired loan data as of December 31, 2020. December 31, 2020 (dollars in thousands) Unpaid Recorded Investment Related Average With No Related Allowance Recorded Construction, land and land development $ 6,969 $ 6,982 $ — $ 2,841 Commercial real estate 11,978 11,105 — 12,190 Residential real estate 1,140 1,122 — 2,142 Commercial, financial & agriculture 42 40 — 203 Consumer & other — — — 123 20,129 19,249 — 17,499 With An Allowance Recorded Construction, land and land development — — — — Commercial real estate 6,292 6,325 1,436 5,945 Residential real estate 1,274 1,230 226 703 Commercial, financial & agriculture 310 310 263 1,118 Consumer & other — — — — 7,876 7,865 1,925 7,766 Purchased Credit Impaired Loans Construction, land and land development 118 94 — 96 Commercial real estate — — — 63 Residential real estate 14 11 4 13 Commercial, financial & agriculture 55 46 — 49 Consumer & other 192 96 81 113 379 247 85 334 Total Construction, land and land development 7,087 7,076 — 2,937 Commercial real estate 18,270 17,430 1,436 18,198 Residential real estate 2,428 2,363 230 2,858 Commercial, financial & agriculture 407 396 263 1,370 Consumer & other 192 96 81 236 $ 28,384 $ 27,361 $ 2,010 $ 25,599 |
Allowance for Loan Losses (Tabl
Allowance for Loan Losses (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Receivables [Abstract] | |
Financing Receivable, Allowance for Credit Loss | The following tables detail activity in the allowance for loan losses, segregated by class of loan, for the three months periods ended March 31, 2021 and March 31, 2020. Allocation of a portion of the allowance to one category of loans does not preclude its availability to absorb losses in other loan categories and periodically may result in reallocation within the provision categories. (dollars in thousands) Construction, land and land development Other commercial real estate Residential real estate Commercial, financial & agricultural Consumer and other Total Three months ended March 31, 2021 Beginning Balance $ 1,013 $ 6,880 $ 2,278 $ 1,713 $ 243 $ 12,127 Charge-offs — — — (15) (11) (26) Recoveries 15 — 66 3 8 92 Provision 25 248 67 (35) 195 500 Ending balance 1,053 7,128 2,411 1,666 435 12,693 Period end amount allocated to Individually evaluated for impairment — 1,315 229 38 6 1,588 Collectively evaluated for impairment 1,015 5,771 2,172 1,528 429 10,915 Purchase credit impaired 38 42 10 100 — 190 Ending Balance 1,053 7,128 2,411 1,666 435 12,693 Loans Individually evaluated for impairment 7,480 15,368 2,300 89 6 25,243 Collectively evaluated for impairment 108,439 521,948 175,910 210,199 20,196 1,036,692 Purchase credit impaired 48 764 1 27 — 840 Ending balance $ 115,967 $ 538,080 $ 178,211 $ 210,315 $ 20,202 $ 1,062,775 (dollars in thousands) Construction, land and land development Other commercial real estate Residential real estate Commercial, financial & agricultural Consumer and other Total Three months ended March 31, 2020 Beginning Balance $ 215 $ 3,908 $ 980 $ 1,657 $ 103 $ 6,863 Charge-offs — (30) (64) (68) (351) (513) Recoveries 13 5 4 1 55 78 Provision 126 938 283 190 419 1,956 Ending balance 354 4,821 1,203 1,780 226 8,384 December 31, 2020 Period end amount allocated to Individually evaluated for impairment — 1,436 226 263 — 1,925 Collectively evaluated for impairment 1,013 5,444 2,048 1,450 162 10,117 Purchase credit impaired — — 4 — 81 85 Ending Balance 1,013 6,880 2,278 1,713 243 12,127 Loans Individually evaluated for impairment 6,982 17,430 2,352 350 — 27,114 Collectively evaluated for impairment 114,017 502,961 180,658 212,984 21,522 1,032,142 Purchase credit impaired 94 — 11 46 96 247 Ending Balance $ 121,093 $ 520,391 $ 183,021 $ 213,380 $ 21,618 $ 1,059,503 |
Leases (Tables)
Leases (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Leases [Abstract] | |
Consolidated Balance Sheet Classification of Assets and Liabilities | The following table represents the consolidated balance sheet classification of the Company’s ROU assets and liabilities. The Company elected not to include short-term leases (i.e., leases with initial terms of twelve months or less), or equipment leases (deemed immaterial) on the consolidated balance sheet. (dollars in thousands) Classification March 31, 2021 December 31, 2020 Assets Operating lease right-of-use assets Other assets $ 193 $ 511 Liabilities Operating lease liabilities Other liabilities 196 517 |
Lessee, Operating Lease, Liability, Maturity | The following table represents the future maturities of the operating lease liabilities and other lease information as of March 31, 2021. (dollars in thousands) Lease Liability 2021 $ 115 2022 83 Total lease payments $ 198 Less: interest (2) Present value of lease liabilities $ 196 Supplemental lease information: Cash paid for amounts included in the measurement of lease liabilities: March 31, 2021 March 31, 2020 Operating cash flows from operating leases (cash payments) $ 58 $ 50 Operating cash flows from operating leases (lease liability addition) — 42 Operating lease right-of-use assets obtained in exchange for leases entered into during the period — 195 |
Other Lease Information | The following table represents the future maturities of the operating lease liabilities and other lease information as of March 31, 2021. (dollars in thousands) Lease Liability 2021 $ 115 2022 83 Total lease payments $ 198 Less: interest (2) Present value of lease liabilities $ 196 Supplemental lease information: Cash paid for amounts included in the measurement of lease liabilities: March 31, 2021 March 31, 2020 Operating cash flows from operating leases (cash payments) $ 58 $ 50 Operating cash flows from operating leases (lease liability addition) — 42 Operating lease right-of-use assets obtained in exchange for leases entered into during the period — 195 |
Borrowings (Tables)
Borrowings (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Debt Disclosure [Abstract] | |
Schedule of Long-term Debt Instruments | The following table presents information regarding the Company’s outstanding borrowings at March 31, 2021 and December 31, 2020: (dollars in thousands) March 31, 2021 December 31, 2020 Federal Home Loan Bank advances $ 22,500 $ 22,500 Paycheck Protection Program (PPP) Liquidity Facility 60,602 106,789 Other borrowings 37,542 37,792 $ 120,644 $ 167,081 |
Schedule of Maturities of Long-term Debt | The aggregate stated maturities of other borrowed money at March 31, 2021 are as follows: (dollars in thousands) Year Amount 2021 $ 5,313 2022 — 2023 3,000 2024 8,000 2025 4,500 2026 and After 39,229 PPPLF 60,602 $ 120,644 |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted | The following table presents earnings per share for the three months ended March 31, 2021 and 2020. (dollars in thousands, except per share data) Three Months Ended 2021 2020 Numerator Net income available to common stockholders $ 4,919 $ 1,603 Denominator Weighted average number of common shares Outstanding for basic earnings per common share 9,499 9,499 Weighted-average number of shares outstanding for diluted earnings per common share 9,499 9,499 Earnings per share - basic $ 0.52 $ 0.17 Earnings per share - diluted $ 0.52 $ 0.17 |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
Summary Of Financial Instrument Outstanding | At March 31, 2021 and December 31, 2020 the following financial instruments were outstanding whose contract amounts represent credit risk: Contract Amount (dollars in thousands) March 31, 2021 December 31, 2020 Loan commitments $ 235,074 $ 198,029 Letters of credit 4,342 3,634 |
Fair Value of Financial Instr_2
Fair Value of Financial Instruments and Fair Value Measurements (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Fair Value, by Balance Sheet Grouping | The carrying amount, estimated fair values, and placement in the fair value hierarchy of the Company’s financial instruments as of March 31, 2021 and December 31, 2020 are as follows: Fair Value Measurements (dollars in thousands) Carrying Estimated Level Level Level March 31, 2021 Assets Cash and short-term investments $ 181,588 $ 181,588 $ 181,588 $ — $ — Investment securities available for sale 433,729 433,729 — 433,729 — Other investments, at cost 2,703 2,703 — 2,703 — Loans held for sale 28,429 28,429 — 28,429 — Loans, net 1,050,082 1,061,554 — — 1,061,554 Liabilities Deposits 1,525,884 1,526,740 — 1,526,740 — Paycheck Protection Program Liquidity Facility 60,602 60,602 — 60,602 — Federal Home Loan Bank advances 22,500 21,312 — 21,312 — Other borrowings 37,542 37,767 — 37,767 — Fair Value Measurements (dollars in thousands) Carrying Estimated Level Level Level December 31, 2020 Assets Cash and short-term investments $ 183,506 $ 183,506 $ 183,506 $ — $ — Investment securities available for sale 380,814 380,814 245 380,569 — Other investments, at cost 3,296 3,296 — 3,296 — Loans held for sale 52,386 52,386 — 52,386 — Loans, net 1,047,376 1,063,785 — — 1,063,785 Liabilities Deposits 1,445,027 1,445,984 — 1,445,984 — Paycheck Protection Program Liquidity Facility 106,789 106,789 — 106,789 Federal Home Loan Bank advances 22,500 20,817 — 20,817 — Other borrowings 37,792 37,792 — 37,792 — |
Fair Value Measurements, Recurring and Nonrecurring | The following table presents the recorded amount of the Company’s assets measured at fair value on a recurring and nonrecurring basis as of March 31, 2021 and December 31, 2020, aggregated by the level in the fair value hierarchy within which those measurements fall. The table below includes only impaired loans with a specific reserve and only other real estate properties with a valuation allowance at March 31, 2021 and December 31, 2020. Those impaired loans and other real estate properties are shown net of the related specific reserves and valuation allowances. Fair Value Measurements at Reporting Date Using (dollars in thousands) Total Fair Value (Level 1) (Level 2) (Level 3) March 31, 2021 Nonrecurring Collateral dependent impaired loans $ 4,984 $ — $ — $ 4,984 Other real estate owned 518 — — 518 Total nonrecurring assets $ 5,502 $ — $ — $ 5,502 Fair Value Measurements at Reporting Date Using (dollars in thousands) Total Fair (Level 1) (Level 2) (Level 3) December 31, 2020 Nonrecurring Collateral dependent impaired loans $ 5,939 $ — $ — 5,939 Other real estate owned 1,006 — — 1,006 Total nonrecurring assets $ 6,945 $ — $ — $ 6,945 |
Fair Value Measurement Inputs and Valuation Techniques | The following table presents quantitative information about the significant unobservable inputs used in the fair value measurements for assets in level 3 of the fair value hierarchy measured on a nonrecurring basis at March 31, 2021 and December 31, 2020. This table is comprised primarily of collateral dependent impaired loans and other real estate owned: (dollars in thousands) March 31, 2021 Valuation Unobservable Range Collateral dependent impaired loans $ 4,984 Appraised Value Discounts to reflect current market conditions, ultimate collectability, and estimated costs to sell 25 % 100 % Other real estate owned 518 Appraised Value/Comparable Sales Discounts to reflect current market conditions and estimated costs to sell — % 20 % (dollars in thousands) December 31, 2020 Valuation Unobservable Range Collateral dependent impaired loans $ 5,939 Appraised Value Discounts to reflect current market conditions, ultimate collectability, and estimated costs to sell 25 % 100 % Other real estate owned 1,006 Appraised Value/Comparable Sales Discounts to reflect current market conditions and estimated costs to sell — % 20 % |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation | The table below presents a reconciliation and statement of income classification of gains and losses for all assets measured at fair value on a recurring basis using significant unobservable inputs (level 3) for the three months ended March 31, 2020. Available for Sale Securities (dollars in thousands) March 31, 2020 Balance, Beginning $ 2,022 Transfers out of Level 3 — Sales — Paydowns (5) Realized Loss on Sale of Security — Unrealized gains (losses) included in Other Comprehensive Income — Balance, Ending $ 2,017 |
Segment Information (Tables)
Segment Information (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Segment Reporting [Abstract] | |
Schedule of Segment Reporting Information, by Segment | The following tables present information reported internally for performance assessment for the three months ended March 31, 2021 and 2020: (dollars in thousands) Bank Mortgage Small Totals Three months ended March 31, 2021 Net Interest Income $ 13,985 $ 168 $ 130 $ 14,283 Provision for Loan Losses 500 — — 500 Noninterest Income 3,005 3,986 1,585 8,576 Noninterest Expenses 11,960 2,793 1,029 15,782 Income Taxes 1,160 354 144 1,658 Segment Profit (Loss) $ 3,370 $ 1,007 $ 542 $ 4,919 Segments Assets at March 31, 2021 $ 1,755,667 $ 27,478 $ 15,901 $ 1,799,046 Full time employees at March 31, 2021 291 51 23 365 (dollars in thousands) Bank Mortgage Small Totals Three months ended March 31, 2020 Net Interest Income $ 12,656 $ 34 $ 14 $ 12,704 Provision for Loan Losses 1,956 — — 1,956 Noninterest Income 3,014 1,253 259 4,526 Noninterest Expenses 11,632 1,195 516 13,343 Income Taxes 368 11 (51) 328 Segment Profit $ 1,714 $ 81 $ (465) $ 1,603 Segments Assets at December 31, 2020 $ 1,709,696 $ 50,266 $ 4,012 $ 1,763,974 Full time employees at March 31, 2020 319 34 12 365 |
Regulatory Capital Matters (Tab
Regulatory Capital Matters (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Banking And Thrift Disclosure [Abstract] | |
Schedule of Compliance with Regulatory Capital Requirements under Banking Regulations | The following table summarizes regulatory capital information as of March 31, 2021 and December 31, 2020 on a consolidated basis and for the subsidiary, as defined. Regulatory capital ratios for March 31, 2021 and December 31, 2020 were calculated in accordance with the Basel III rules. (dollars in thousands) Actual For Capital To Be Well Amount Ratio Amount Ratio Amount Ratio As of March 31, 2021 Total Capital to Risk-Weighted Assets Consolidated $ 159,767 13.76 % $ 92,888 8.00 % N/A N/A Colony Bank 163,639 13.81 94,794 8.00 $ 118,493 10.00 % Tier I Capital to Risk-Weighted Assets Consolidated 147,074 12.49 70,652 6.00 N/A N/A Colony Bank 150,946 12.74 71,089 6.00 94,786 8.00 Common Equity Tier I Capital to Risk-Weighted Assets Consolidated 123,574 10.49 53,011 4.50 N/A N/A Colony Bank 150,946 12.74 53,317 4.50 77,013 6.50 Tier I Capital to Average Assets Consolidated 147,074 8.70 67,620 4.00 N/A N/A Colony Bank 150,946 9.05 66,716 4.00 83,396 5.00 (dollars in thousands) Actual For Capital To Be Well Amount Ratio Amount Ratio Amount Ratio As of December 31, 2020 Total Capital to Risk-Weighted Assets Consolidated $ 155,447 13.78 % $ 90,245 8.00 % N/A N/A Colony Bank 164,050 14.55 90,199 8.00 $ 112,749 10.00 % Tier I Capital to Risk-Weighted Assets Consolidated 143,320 12.71 67,657 6.00 N/A N/A Colony Bank 151,923 13.48 67,622 6.00 90,162 8.00 Common Equity Tier I Capital to Risk-Weighted Assets Consolidated 119,820 10.62 50,771 4.50 N/A N/A Colony Bank 151,923 13.48 50,716 4.50 73,257 6.50 Tier I Capital to Average Assets Consolidated 143,320 8.49 67,524 4.00 N/A N/A Colony Bank 151,923 9.12 66,633 4.00 83,291 5.00 |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Details) | 3 Months Ended |
Mar. 31, 2021 | |
Accounting Policies [Abstract] | |
Percentage of Loan Portfolio Concentrated in Loans Secured by Real Estate | 78.00% |
Investment Securities - Schedul
Investment Securities - Schedule of Investment Securities (Details) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Securities Available for Sale: | ||
Amortized Cost | $ 431,387 | $ 372,231 |
Gross Unrealized Gains | 5,882 | 8,997 |
Gross Unrealized Losses | (3,540) | (414) |
Fair Value | 433,729 | 380,814 |
U.S. treasury securities | ||
Securities Available for Sale: | ||
Amortized Cost | 245 | 245 |
Gross Unrealized Gains | 0 | 0 |
Gross Unrealized Losses | 0 | 0 |
Fair Value | 245 | 245 |
U.S. agency | ||
Securities Available for Sale: | ||
Amortized Cost | 9,863 | 1,000 |
Gross Unrealized Gains | 11 | 4 |
Gross Unrealized Losses | (70) | 0 |
Fair Value | 9,804 | 1,004 |
Mutual fund | ||
Securities Available for Sale: | ||
Amortized Cost | 3,998 | |
Gross Unrealized Gains | 0 | |
Gross Unrealized Losses | 0 | |
Fair Value | 3,998 | |
State, county & municipal securities | ||
Securities Available for Sale: | ||
Amortized Cost | 73,041 | 61,298 |
Gross Unrealized Gains | 356 | 1,155 |
Gross Unrealized Losses | (1,073) | (65) |
Fair Value | 72,324 | 62,388 |
Corporate debt securities | ||
Securities Available for Sale: | ||
Amortized Cost | 5,250 | 4,250 |
Gross Unrealized Gains | 1 | 1 |
Gross Unrealized Losses | (22) | (1) |
Fair Value | 5,229 | 4,250 |
Mortgage-backed securities | ||
Securities Available for Sale: | ||
Amortized Cost | 338,990 | 305,438 |
Gross Unrealized Gains | 5,514 | 7,837 |
Gross Unrealized Losses | (2,375) | (348) |
Fair Value | $ 342,129 | $ 312,927 |
Investment Securities - Amortiz
Investment Securities - Amortized Cost and Fair Value of Investment Securities by Contractual Maturity (Details) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Amortized Cost | ||
Due in one year or less | $ 6,243 | |
Due after one year through five years | 1,910 | |
Due after five years through ten years | 33,362 | |
Due after ten years | 50,882 | |
Total Amortized Cost | 92,397 | |
Mortgage-backed securities | 338,990 | |
Amortized Cost | 431,387 | $ 372,231 |
Fair Value | ||
Due in one year or less | 6,244 | |
Due after one year through five years | 1,948 | |
Due after five years through ten years | 33,152 | |
Due after ten years | 50,256 | |
Total Fair Value | 91,600 | |
Mortgage-backed securities | 342,129 | |
Fair Value | $ 433,729 | $ 380,814 |
Investment Securities - (Detail
Investment Securities - (Details Textual) | 3 Months Ended | ||
Mar. 31, 2021USD ($)security | Mar. 31, 2020USD ($) | Dec. 31, 2020USD ($) | |
Investments, Debt and Equity Securities [Abstract] | |||
Proceeds from sale of investment securities available for sale | $ 1,643,000 | $ 15,314,000 | |
Gross realized gain on sale | 1,000 | 314,000 | |
Gross realized loss on sale | 5,000 | $ 215,000 | |
Investment securities pledged as collateral | $ 117,700,000 | $ 126,500,000 | |
Number of securities that have unrealized losses | security | 96 | ||
Securities deemed to be other than temporary | $ 0 |
Investment Securities - Continu
Investment Securities - Continuous Unrealized Loss Position (Details) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Fair Value | ||
Less Than 12 Months | $ 170,447 | $ 38,116 |
12 Months or Greater | 4,005 | 3,949 |
Fair Value | 174,452 | 42,065 |
Gross Unrealized Losses | ||
Less Than 12 Months | (3,254) | (143) |
12 Months or Greater | (216) | (271) |
Total | (3,470) | (414) |
U.S. agency | ||
Fair Value | ||
Less Than 12 Months | 8,662 | |
12 Months or Greater | 0 | |
Fair Value | 8,662 | |
Gross Unrealized Losses | ||
Less Than 12 Months | (70) | |
12 Months or Greater | 0 | |
Total | (70) | |
State, county & municipal securities | ||
Fair Value | ||
Less Than 12 Months | 47,942 | 8,282 |
12 Months or Greater | 0 | 0 |
Fair Value | 47,942 | 8,282 |
Gross Unrealized Losses | ||
Less Than 12 Months | (1,073) | (65) |
12 Months or Greater | 0 | 0 |
Total | (1,073) | (65) |
Corporate debt securities | ||
Fair Value | ||
Less Than 12 Months | 1,728 | 999 |
12 Months or Greater | 0 | 0 |
Fair Value | 1,728 | 999 |
Gross Unrealized Losses | ||
Less Than 12 Months | (22) | (1) |
12 Months or Greater | 0 | 0 |
Total | (22) | (1) |
Mortgage-backed securities | ||
Fair Value | ||
Less Than 12 Months | 120,777 | 28,835 |
12 Months or Greater | 4,005 | 3,949 |
Fair Value | 124,782 | 32,784 |
Gross Unrealized Losses | ||
Less Than 12 Months | (2,159) | (77) |
12 Months or Greater | (216) | (271) |
Total | $ (2,375) | $ (348) |
Loans - Segregated by Class of
Loans - Segregated by Class of Loans (Details) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | $ 1,062,775 | $ 1,059,503 |
Legacy Loans | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 992,993 | 974,573 |
Purchased Loans | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 69,783 | 84,930 |
Construction, land and land development | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 115,967 | 121,093 |
Other commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 538,080 | 520,391 |
Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 654,047 | 641,484 |
Commercial real estate | Legacy Loans | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 609,189 | 587,022 |
Commercial real estate | Purchased Loans | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 44,860 | 54,462 |
Commercial real estate | Construction, land and land development | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 115,967 | 121,093 |
Commercial real estate | Construction, land and land development | Legacy Loans | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 109,585 | 109,577 |
Commercial real estate | Construction, land and land development | Purchased Loans | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 6,383 | 11,516 |
Commercial real estate | Other commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 538,080 | 520,391 |
Commercial real estate | Other commercial real estate | Legacy Loans | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 499,604 | 477,445 |
Commercial real estate | Other commercial real estate | Purchased Loans | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 38,477 | 42,946 |
Residential real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 178,211 | 183,021 |
Residential real estate | Legacy Loans | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 165,887 | 167,714 |
Residential real estate | Purchased Loans | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 12,324 | 15,307 |
Commercial, financial & agricultural | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 210,315 | 213,380 |
Commercial, financial & agricultural | Paycheck Protection Program, CARES Act | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 102,600 | 101,100 |
Commercial, financial & agricultural | Legacy Loans | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 199,862 | 200,800 |
Commercial, financial & agricultural | Purchased Loans | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 10,452 | 12,580 |
Consumer and other | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 20,202 | 21,618 |
Consumer and other | Legacy Loans | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 18,055 | 19,037 |
Consumer and other | Purchased Loans | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | $ 2,147 | $ 2,581 |
Loans - (Details Textual)
Loans - (Details Textual) | 3 Months Ended | ||
Mar. 31, 2021USD ($)loan | Mar. 31, 2020USD ($)loan | Dec. 31, 2020USD ($) | |
Loans and Leases Receivable Disclosure [Line Items] | |||
Outstanding balance of high risk loans, minimum | $ 250,000 | ||
Interest income on impaired loans | 238,000 | $ 50,000 | |
Unfunded commitments to lend | $ 0 | ||
Number of loans that subsequently defaulted | loan | 0 | 0 | |
Loans | $ 1,062,775,000 | $ 1,059,503,000 | |
Legacy Loans | |||
Loans and Leases Receivable Disclosure [Line Items] | |||
Loans | 992,993,000 | 974,573,000 | |
Other commercial real estate | |||
Loans and Leases Receivable Disclosure [Line Items] | |||
Loans | $ 538,080,000 | 520,391,000 | |
Construction, land and land development | |||
Loans and Leases Receivable Disclosure [Line Items] | |||
Loan contracts restructured | loan | 1 | ||
Troubled debt restructuring | $ 511,000 | ||
Loans | 115,967,000 | 121,093,000 | |
Loan Modifications, CARES Act | |||
Loans and Leases Receivable Disclosure [Line Items] | |||
Loans | 12,700,000 | ||
Commercial, financial & agricultural | |||
Loans and Leases Receivable Disclosure [Line Items] | |||
Loans | 210,315,000 | 213,380,000 | |
Commercial, financial & agricultural | Legacy Loans | |||
Loans and Leases Receivable Disclosure [Line Items] | |||
Loans | $ 199,862,000 | $ 200,800,000 |
Loans - Loan Portfolio by Credi
Loans - Loan Portfolio by Credit Quality Indicator (Details) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | $ 1,062,775 | $ 1,059,503 |
Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 654,047 | 641,484 |
Residential real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 178,211 | 183,021 |
Commercial, financial & agricultural | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 210,315 | 213,380 |
Consumer and other | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 20,202 | 21,618 |
Construction, land and land development | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 115,967 | 121,093 |
Construction, land and land development | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 115,967 | 121,093 |
Other commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 538,080 | 520,391 |
Other commercial real estate | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 538,080 | 520,391 |
Legacy Loans | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 992,993 | 974,573 |
Legacy Loans | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 609,189 | 587,022 |
Legacy Loans | Residential real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 165,887 | 167,714 |
Legacy Loans | Commercial, financial & agricultural | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 199,862 | 200,800 |
Legacy Loans | Consumer and other | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 18,055 | 19,037 |
Legacy Loans | Construction, land and land development | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 109,585 | 109,577 |
Legacy Loans | Other commercial real estate | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 499,604 | 477,445 |
Purchased Loans | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 69,783 | 84,930 |
Purchased Loans | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 44,860 | 54,462 |
Purchased Loans | Residential real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 12,324 | 15,307 |
Purchased Loans | Commercial, financial & agricultural | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 10,452 | 12,580 |
Purchased Loans | Consumer and other | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 2,147 | 2,581 |
Purchased Loans | Construction, land and land development | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 6,383 | 11,516 |
Purchased Loans | Other commercial real estate | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 38,477 | 42,946 |
Pass | Legacy Loans | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 921,469 | 903,355 |
Pass | Legacy Loans | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 550,990 | 529,945 |
Pass | Legacy Loans | Residential real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 156,665 | 157,927 |
Pass | Legacy Loans | Commercial, financial & agricultural | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 196,052 | 196,749 |
Pass | Legacy Loans | Consumer and other | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 17,762 | 18,734 |
Pass | Legacy Loans | Construction, land and land development | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 98,634 | 99,430 |
Pass | Legacy Loans | Other commercial real estate | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 452,356 | 430,515 |
Pass | Purchased Loans | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 61,024 | 79,571 |
Pass | Purchased Loans | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 38,654 | 52,100 |
Pass | Purchased Loans | Residential real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 11,944 | 14,909 |
Pass | Purchased Loans | Commercial, financial & agricultural | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 8,283 | 10,198 |
Pass | Purchased Loans | Consumer and other | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 2,143 | 2,364 |
Pass | Purchased Loans | Construction, land and land development | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 6,263 | 11,275 |
Pass | Purchased Loans | Other commercial real estate | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 32,391 | 40,825 |
Special Mention | Legacy Loans | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 39,559 | 43,368 |
Special Mention | Legacy Loans | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 33,545 | 36,519 |
Special Mention | Legacy Loans | Residential real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 3,090 | 3,855 |
Special Mention | Legacy Loans | Commercial, financial & agricultural | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 2,795 | 2,870 |
Special Mention | Legacy Loans | Consumer and other | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 129 | 124 |
Special Mention | Legacy Loans | Construction, land and land development | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 3,244 | 2,940 |
Special Mention | Legacy Loans | Other commercial real estate | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 30,301 | 33,579 |
Special Mention | Purchased Loans | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 5,538 | 2,434 |
Special Mention | Purchased Loans | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 3,543 | 294 |
Special Mention | Purchased Loans | Residential real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 301 | 312 |
Special Mention | Purchased Loans | Commercial, financial & agricultural | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 1,690 | 1,803 |
Special Mention | Purchased Loans | Consumer and other | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 4 | 25 |
Special Mention | Purchased Loans | Construction, land and land development | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 120 | 241 |
Special Mention | Purchased Loans | Other commercial real estate | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 3,423 | 53 |
Substandard | Legacy Loans | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 31,964 | 27,850 |
Substandard | Legacy Loans | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 24,653 | 20,558 |
Substandard | Legacy Loans | Residential real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 6,132 | 5,932 |
Substandard | Legacy Loans | Commercial, financial & agricultural | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 1,015 | 1,181 |
Substandard | Legacy Loans | Consumer and other | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 164 | 179 |
Substandard | Legacy Loans | Construction, land and land development | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 7,707 | 7,207 |
Substandard | Legacy Loans | Other commercial real estate | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 16,946 | 13,351 |
Substandard | Purchased Loans | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 3,221 | 2,925 |
Substandard | Purchased Loans | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 2,663 | 2,068 |
Substandard | Purchased Loans | Residential real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 78 | 86 |
Substandard | Purchased Loans | Commercial, financial & agricultural | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 480 | 579 |
Substandard | Purchased Loans | Consumer and other | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 0 | 192 |
Substandard | Purchased Loans | Construction, land and land development | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | 0 | 0 |
Substandard | Purchased Loans | Other commercial real estate | Commercial real estate | ||
Loans and Leases Receivable Disclosure [Line Items] | ||
Loans | $ 2,663 | $ 2,068 |
Loans - Age Analysis of Past Du
Loans - Age Analysis of Past Due Loans and Nonaccrual Loans (Details) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Financing Receivable, Past Due [Line Items] | ||
Loans | $ 1,062,775 | $ 1,059,503 |
Legacy Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 789 | 2,408 |
Nonaccrual Loans | 8,698 | 6,610 |
Current Loans | 983,506 | 965,555 |
Loans | 992,993 | 974,573 |
Purchased Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 44 | 684 |
Nonaccrual Loans | 1,979 | 2,518 |
Current Loans | 67,760 | 81,728 |
Loans | 69,783 | 84,930 |
30-89 Days Past Due | Legacy Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 789 | 2,408 |
30-89 Days Past Due | Purchased Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 44 | 684 |
90 Days or More Past Due | Legacy Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 0 | 0 |
90 Days or More Past Due | Purchased Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 0 | 0 |
Construction, land and land development | ||
Financing Receivable, Past Due [Line Items] | ||
Loans | 115,967 | 121,093 |
Other commercial real estate | ||
Financing Receivable, Past Due [Line Items] | ||
Loans | 538,080 | 520,391 |
Commercial real estate | ||
Financing Receivable, Past Due [Line Items] | ||
Loans | 654,047 | 641,484 |
Commercial real estate | Legacy Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 132 | 1,543 |
Nonaccrual Loans | 5,228 | 2,625 |
Current Loans | 603,829 | 582,854 |
Loans | 609,189 | 587,022 |
Commercial real estate | Purchased Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 0 | 544 |
Nonaccrual Loans | 1,883 | 2,185 |
Current Loans | 42,977 | 51,733 |
Loans | 44,860 | 54,462 |
Commercial real estate | 30-89 Days Past Due | Legacy Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 132 | 1,543 |
Commercial real estate | 30-89 Days Past Due | Purchased Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 0 | 544 |
Commercial real estate | 90 Days or More Past Due | Legacy Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 0 | 0 |
Commercial real estate | 90 Days or More Past Due | Purchased Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 0 | 0 |
Commercial real estate | Construction, land and land development | ||
Financing Receivable, Past Due [Line Items] | ||
Loans | 115,967 | 121,093 |
Commercial real estate | Construction, land and land development | Legacy Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 24 | 1,314 |
Nonaccrual Loans | 74 | 80 |
Current Loans | 109,487 | 108,183 |
Loans | 109,585 | 109,577 |
Commercial real estate | Construction, land and land development | Purchased Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 0 | 0 |
Nonaccrual Loans | 0 | 117 |
Current Loans | 6,383 | 11,399 |
Loans | 6,383 | 11,516 |
Commercial real estate | Construction, land and land development | 30-89 Days Past Due | Legacy Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 24 | 1,314 |
Commercial real estate | Construction, land and land development | 30-89 Days Past Due | Purchased Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 0 | 0 |
Commercial real estate | Construction, land and land development | 90 Days or More Past Due | Legacy Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 0 | 0 |
Commercial real estate | Construction, land and land development | 90 Days or More Past Due | Purchased Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 0 | 0 |
Commercial real estate | Other commercial real estate | ||
Financing Receivable, Past Due [Line Items] | ||
Loans | 538,080 | 520,391 |
Commercial real estate | Other commercial real estate | Legacy Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 108 | 229 |
Nonaccrual Loans | 5,154 | 2,545 |
Current Loans | 494,342 | 474,671 |
Loans | 499,604 | 477,445 |
Commercial real estate | Other commercial real estate | Purchased Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 0 | 544 |
Nonaccrual Loans | 1,883 | 2,068 |
Current Loans | 36,594 | 40,334 |
Loans | 38,477 | 42,946 |
Commercial real estate | Other commercial real estate | 30-89 Days Past Due | Legacy Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 108 | 229 |
Commercial real estate | Other commercial real estate | 30-89 Days Past Due | Purchased Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 0 | 544 |
Commercial real estate | Other commercial real estate | 90 Days or More Past Due | Legacy Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 0 | 0 |
Commercial real estate | Other commercial real estate | 90 Days or More Past Due | Purchased Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 0 | 0 |
Residential real estate | ||
Financing Receivable, Past Due [Line Items] | ||
Loans | 178,211 | 183,021 |
Residential real estate | Legacy Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 471 | 667 |
Nonaccrual Loans | 2,572 | 2,873 |
Current Loans | 162,844 | 164,174 |
Loans | 165,887 | 167,714 |
Residential real estate | Purchased Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 17 | 15 |
Nonaccrual Loans | 69 | 85 |
Current Loans | 12,238 | 15,207 |
Loans | 12,324 | 15,307 |
Residential real estate | 30-89 Days Past Due | Legacy Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 471 | 667 |
Residential real estate | 30-89 Days Past Due | Purchased Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 17 | 15 |
Residential real estate | 90 Days or More Past Due | Legacy Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 0 | 0 |
Residential real estate | 90 Days or More Past Due | Purchased Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 0 | 0 |
Commercial, financial & agricultural | ||
Financing Receivable, Past Due [Line Items] | ||
Loans | 210,315 | 213,380 |
Commercial, financial & agricultural | Legacy Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 149 | 150 |
Nonaccrual Loans | 810 | 1,010 |
Current Loans | 198,903 | 199,640 |
Loans | 199,862 | 200,800 |
Commercial, financial & agricultural | Purchased Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 27 | 125 |
Nonaccrual Loans | 27 | 55 |
Current Loans | 10,398 | 12,400 |
Loans | 10,452 | 12,580 |
Commercial, financial & agricultural | 30-89 Days Past Due | Legacy Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 149 | 150 |
Commercial, financial & agricultural | 30-89 Days Past Due | Purchased Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 27 | 125 |
Commercial, financial & agricultural | 90 Days or More Past Due | Legacy Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 0 | 0 |
Commercial, financial & agricultural | 90 Days or More Past Due | Purchased Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 0 | 0 |
Consumer and other | ||
Financing Receivable, Past Due [Line Items] | ||
Loans | 20,202 | 21,618 |
Consumer and other | Legacy Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 37 | 48 |
Nonaccrual Loans | 88 | 102 |
Current Loans | 17,930 | 18,887 |
Loans | 18,055 | 19,037 |
Consumer and other | Purchased Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 0 | 0 |
Nonaccrual Loans | 0 | 193 |
Current Loans | 2,147 | 2,388 |
Loans | 2,147 | 2,581 |
Consumer and other | 30-89 Days Past Due | Legacy Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 37 | 48 |
Consumer and other | 30-89 Days Past Due | Purchased Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 0 | 0 |
Consumer and other | 90 Days or More Past Due | Legacy Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | 0 | 0 |
Consumer and other | 90 Days or More Past Due | Purchased Loans | ||
Financing Receivable, Past Due [Line Items] | ||
Accruing Loans Past Due | $ 0 | $ 0 |
Loans - Impaired Loan Data (Det
Loans - Impaired Loan Data (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended |
Mar. 31, 2021 | Dec. 31, 2020 | |
Unpaid Contractual Principal Balance | ||
With No Related Allowance Recorded | $ 19,509 | $ 20,129 |
With An Allowance Recorded | 6,511 | 7,876 |
Loans Including Purchased Credit Impaired Loans | 27,176 | 28,384 |
Recorded Investment | ||
With No Related Allowance Recorded | 18,671 | 19,249 |
With An Allowance Recorded | 6,572 | 7,865 |
Loans Including Purchased Credit Impaired Loans | 26,083 | 27,361 |
Related Allowance | ||
With An Allowance Recorded | 1,588 | 1,925 |
Total Impaired Loans | 1,778 | 2,010 |
Average Recorded Investment | ||
With No Related Allowance Recorded | 19,378 | 17,499 |
With An Allowance Recorded | 7,187 | 7,766 |
Loans Including Purchased Credit Impaired Loans | 27,109 | 25,599 |
Purchase credit impaired | ||
Unpaid Contractual Principal Balance | ||
Loans Including Purchased Credit Impaired Loans | 1,156 | 379 |
Recorded Investment | ||
Loans Including Purchased Credit Impaired Loans | 840 | 247 |
Related Allowance | ||
With An Allowance Recorded | 190 | 85 |
Purchased Credit Impaired Loans | 190 | 85 |
Average Recorded Investment | ||
Loans Including Purchased Credit Impaired Loans | 544 | 334 |
Construction, land and land development | ||
Unpaid Contractual Principal Balance | ||
With No Related Allowance Recorded | 7,480 | 6,969 |
With An Allowance Recorded | 0 | 0 |
Loans Including Purchased Credit Impaired Loans | 7,596 | 7,087 |
Recorded Investment | ||
With No Related Allowance Recorded | 7,480 | 6,982 |
With An Allowance Recorded | 0 | 0 |
Loans Including Purchased Credit Impaired Loans | 7,528 | 7,076 |
Related Allowance | ||
With An Allowance Recorded | 0 | 0 |
Total Impaired Loans | 38 | 0 |
Average Recorded Investment | ||
With No Related Allowance Recorded | 7,231 | 2,841 |
With An Allowance Recorded | 0 | 0 |
Loans Including Purchased Credit Impaired Loans | 7,302 | 2,937 |
Construction, land and land development | Purchase credit impaired | ||
Unpaid Contractual Principal Balance | ||
Loans Including Purchased Credit Impaired Loans | 116 | 118 |
Recorded Investment | ||
Loans Including Purchased Credit Impaired Loans | 48 | 94 |
Related Allowance | ||
With An Allowance Recorded | 38 | 0 |
Purchased Credit Impaired Loans | 38 | 0 |
Average Recorded Investment | ||
Loans Including Purchased Credit Impaired Loans | 71 | 96 |
Commercial real estate | ||
Unpaid Contractual Principal Balance | ||
With No Related Allowance Recorded | 10,979 | 11,978 |
With An Allowance Recorded | 5,242 | 6,292 |
Loans Including Purchased Credit Impaired Loans | 17,001 | 18,270 |
Recorded Investment | ||
With No Related Allowance Recorded | 10,121 | 11,105 |
With An Allowance Recorded | 5,247 | 6,325 |
Loans Including Purchased Credit Impaired Loans | 16,132 | 17,430 |
Related Allowance | ||
With An Allowance Recorded | 1,315 | 1,436 |
Total Impaired Loans | 1,357 | 1,436 |
Average Recorded Investment | ||
With No Related Allowance Recorded | 11,042 | 12,190 |
With An Allowance Recorded | 5,783 | 5,945 |
Loans Including Purchased Credit Impaired Loans | 17,207 | 18,198 |
Commercial real estate | Purchase credit impaired | ||
Unpaid Contractual Principal Balance | ||
Loans Including Purchased Credit Impaired Loans | 780 | 0 |
Recorded Investment | ||
Loans Including Purchased Credit Impaired Loans | 764 | 0 |
Related Allowance | ||
With An Allowance Recorded | 42 | 0 |
Purchased Credit Impaired Loans | 42 | 0 |
Average Recorded Investment | ||
Loans Including Purchased Credit Impaired Loans | 382 | 63 |
Residential real estate | ||
Unpaid Contractual Principal Balance | ||
With No Related Allowance Recorded | 1,047 | 1,140 |
With An Allowance Recorded | 1,177 | 1,274 |
Loans Including Purchased Credit Impaired Loans | 2,237 | 2,428 |
Recorded Investment | ||
With No Related Allowance Recorded | 1,067 | 1,122 |
With An Allowance Recorded | 1,233 | 1,230 |
Loans Including Purchased Credit Impaired Loans | 2,301 | 2,363 |
Related Allowance | ||
With An Allowance Recorded | 229 | 226 |
Total Impaired Loans | 239 | 230 |
Average Recorded Investment | ||
With No Related Allowance Recorded | 1,084 | 2,142 |
With An Allowance Recorded | 1,203 | 703 |
Loans Including Purchased Credit Impaired Loans | 2,293 | 2,858 |
Residential real estate | Purchase credit impaired | ||
Unpaid Contractual Principal Balance | ||
Loans Including Purchased Credit Impaired Loans | 13 | 14 |
Recorded Investment | ||
Loans Including Purchased Credit Impaired Loans | 1 | 11 |
Related Allowance | ||
With An Allowance Recorded | 10 | 4 |
Purchased Credit Impaired Loans | 10 | 4 |
Average Recorded Investment | ||
Loans Including Purchased Credit Impaired Loans | 6 | 13 |
Commercial, financial & agricultural | ||
Unpaid Contractual Principal Balance | ||
With No Related Allowance Recorded | 3 | 42 |
With An Allowance Recorded | 86 | 310 |
Loans Including Purchased Credit Impaired Loans | 336 | 407 |
Recorded Investment | ||
With No Related Allowance Recorded | 3 | 40 |
With An Allowance Recorded | 86 | 310 |
Loans Including Purchased Credit Impaired Loans | 116 | 396 |
Related Allowance | ||
With An Allowance Recorded | 38 | 263 |
Total Impaired Loans | 138 | 263 |
Average Recorded Investment | ||
With No Related Allowance Recorded | 21 | 203 |
With An Allowance Recorded | 198 | 1,118 |
Loans Including Purchased Credit Impaired Loans | 256 | 1,370 |
Commercial, financial & agricultural | Purchase credit impaired | ||
Unpaid Contractual Principal Balance | ||
Loans Including Purchased Credit Impaired Loans | 247 | 55 |
Recorded Investment | ||
Loans Including Purchased Credit Impaired Loans | 27 | 46 |
Related Allowance | ||
With An Allowance Recorded | 100 | 0 |
Purchased Credit Impaired Loans | 100 | 0 |
Average Recorded Investment | ||
Loans Including Purchased Credit Impaired Loans | 37 | 49 |
Consumer and other | ||
Unpaid Contractual Principal Balance | ||
With No Related Allowance Recorded | 0 | 0 |
With An Allowance Recorded | 6 | 0 |
Loans Including Purchased Credit Impaired Loans | 6 | 192 |
Recorded Investment | ||
With No Related Allowance Recorded | 0 | 0 |
With An Allowance Recorded | 6 | 0 |
Loans Including Purchased Credit Impaired Loans | 6 | 96 |
Related Allowance | ||
With An Allowance Recorded | 6 | 0 |
Total Impaired Loans | 6 | 81 |
Average Recorded Investment | ||
With No Related Allowance Recorded | 0 | 123 |
With An Allowance Recorded | 3 | 0 |
Loans Including Purchased Credit Impaired Loans | 51 | 236 |
Consumer and other | Purchase credit impaired | ||
Unpaid Contractual Principal Balance | ||
Loans Including Purchased Credit Impaired Loans | 0 | 192 |
Recorded Investment | ||
Loans Including Purchased Credit Impaired Loans | 0 | 96 |
Related Allowance | ||
With An Allowance Recorded | 0 | 81 |
Purchased Credit Impaired Loans | 0 | 81 |
Average Recorded Investment | ||
Loans Including Purchased Credit Impaired Loans | $ 48 | $ 113 |
Allowance for Loan Losses - Seg
Allowance for Loan Losses - Segregated by Class of Loan (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Dec. 31, 2020 | |
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |||
Beginning Balance | $ 12,127 | $ 6,863 | |
Charge-offs | (26) | (513) | |
Recoveries | 92 | 78 | |
Provision | 500 | 1,956 | |
Ending balance | 12,693 | 8,384 | |
Period end amount allocated to | |||
Individually evaluated for impairment | 1,588 | $ 1,925 | |
Collectively evaluated for impairment | 10,915 | 10,117 | |
Purchase credit impaired | 1,588 | 1,925 | |
Loans | |||
Individually evaluated for impairment | 25,243 | 27,114 | |
Collectively evaluated for impairment | 1,036,692 | 1,032,142 | |
Purchase credit impaired | 26,083 | 27,361 | |
Loans | 1,062,775 | 1,059,503 | |
Residential real estate | |||
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |||
Beginning Balance | 2,278 | 980 | |
Charge-offs | 0 | (64) | |
Recoveries | 66 | 4 | |
Provision | 67 | 283 | |
Ending balance | 2,411 | 1,203 | |
Period end amount allocated to | |||
Individually evaluated for impairment | 229 | 226 | |
Collectively evaluated for impairment | 2,172 | 2,048 | |
Purchase credit impaired | 229 | 226 | |
Loans | |||
Individually evaluated for impairment | 2,300 | 2,352 | |
Collectively evaluated for impairment | 175,910 | 180,658 | |
Purchase credit impaired | 2,301 | 2,363 | |
Loans | 178,211 | 183,021 | |
Commercial, financial & agricultural | |||
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |||
Beginning Balance | 1,713 | 1,657 | |
Charge-offs | (15) | (68) | |
Recoveries | 3 | 1 | |
Provision | (35) | 190 | |
Ending balance | 1,666 | 1,780 | |
Period end amount allocated to | |||
Individually evaluated for impairment | 38 | 263 | |
Collectively evaluated for impairment | 1,528 | 1,450 | |
Purchase credit impaired | 38 | 263 | |
Loans | |||
Individually evaluated for impairment | 89 | 350 | |
Collectively evaluated for impairment | 210,199 | 212,984 | |
Purchase credit impaired | 116 | 396 | |
Loans | 210,315 | 213,380 | |
Consumer and other | |||
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |||
Beginning Balance | 243 | 103 | |
Charge-offs | (11) | (351) | |
Recoveries | 8 | 55 | |
Provision | 195 | 419 | |
Ending balance | 435 | 226 | |
Period end amount allocated to | |||
Individually evaluated for impairment | 6 | 0 | |
Collectively evaluated for impairment | 429 | 162 | |
Purchase credit impaired | 6 | 0 | |
Loans | |||
Individually evaluated for impairment | 6 | 0 | |
Collectively evaluated for impairment | 20,196 | 21,522 | |
Purchase credit impaired | 6 | 96 | |
Loans | 20,202 | 21,618 | |
Purchase credit impaired | |||
Period end amount allocated to | |||
Purchase credit impaired | 190 | 85 | |
Loans | |||
Purchase credit impaired | 840 | 247 | |
Purchase credit impaired | Residential real estate | |||
Period end amount allocated to | |||
Purchase credit impaired | 10 | 4 | |
Loans | |||
Purchase credit impaired | 1 | 11 | |
Purchase credit impaired | Commercial, financial & agricultural | |||
Period end amount allocated to | |||
Purchase credit impaired | 100 | 0 | |
Loans | |||
Purchase credit impaired | 27 | 46 | |
Purchase credit impaired | Consumer and other | |||
Period end amount allocated to | |||
Purchase credit impaired | 0 | 81 | |
Loans | |||
Purchase credit impaired | 0 | 96 | |
Construction, land and land development | |||
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |||
Beginning Balance | 1,013 | 215 | |
Charge-offs | 0 | 0 | |
Recoveries | 15 | 13 | |
Provision | 25 | 126 | |
Ending balance | 1,053 | 354 | |
Period end amount allocated to | |||
Individually evaluated for impairment | 0 | 0 | |
Collectively evaluated for impairment | 1,015 | 1,013 | |
Purchase credit impaired | 0 | 0 | |
Loans | |||
Individually evaluated for impairment | 7,480 | 6,982 | |
Collectively evaluated for impairment | 108,439 | 114,017 | |
Purchase credit impaired | 7,528 | 7,076 | |
Loans | 115,967 | 121,093 | |
Construction, land and land development | Purchase credit impaired | |||
Period end amount allocated to | |||
Purchase credit impaired | 38 | 0 | |
Loans | |||
Purchase credit impaired | 48 | 94 | |
Other commercial real estate | |||
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |||
Beginning Balance | 6,880 | 3,908 | |
Charge-offs | 0 | (30) | |
Recoveries | 0 | 5 | |
Provision | 248 | 938 | |
Ending balance | 7,128 | $ 4,821 | |
Period end amount allocated to | |||
Individually evaluated for impairment | 1,315 | 1,436 | |
Collectively evaluated for impairment | 5,771 | 5,444 | |
Purchase credit impaired | 1,315 | 1,436 | |
Loans | |||
Individually evaluated for impairment | 15,368 | 17,430 | |
Collectively evaluated for impairment | 521,948 | 502,961 | |
Purchase credit impaired | 16,132 | 17,430 | |
Loans | 538,080 | 520,391 | |
Other commercial real estate | Purchase credit impaired | |||
Period end amount allocated to | |||
Purchase credit impaired | 42 | 0 | |
Loans | |||
Purchase credit impaired | $ 764 | $ 0 |
Allowance for Loan Losses (Deta
Allowance for Loan Losses (Details Textual) | Mar. 31, 2021USD ($) |
Receivables [Abstract] | |
Outstanding balance of high risk loans, minimum | $ 250,000 |
Leases - Balance Sheet Classifi
Leases - Balance Sheet Classification of Operating Lease Right-of-use Assets and Lease Liabilities (Details) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Assets | ||
Operating lease right-of-use assets | $ 193 | $ 511 |
Liabilities | ||
Operating lease liabilities | $ 196 | $ 517 |
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] | Other assets | Other assets |
Operating Lease, Liability, Statement of Financial Position [Extensible List] | Other liabilities | Other liabilities |
Leases (Details Textual)
Leases (Details Textual) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Leases [Abstract] | ||
Operating lease cost | $ 59 | $ 31 |
Weighted average remaining lease term (in years) | 1 year 8 months 26 days | |
Weighted average discount rate (as a percent) | 1.34% |
Leases - Future Maturities of O
Leases - Future Maturities of Operating Lease Liabilities and Other Lease Information (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Dec. 31, 2020 | |
Lease Liability | |||
2021 | $ 115 | ||
2022 | 83 | ||
Total lease payments | 198 | ||
Less: interest | (2) | ||
Present value of lease liabilities | 196 | $ 517 | |
Cash paid for amounts included in the measurement of lease liabilities: | |||
Operating cash flows from operating leases (cash payments) | 58 | $ 50 | |
Operating cash flows from operating leases (lease liability addition) | 0 | 42 | |
Operating lease right-of-use assets obtained in exchange for leases entered into during the period | $ 0 | $ 195 |
Borrowings - Summary of Other B
Borrowings - Summary of Other Borrowed Money (Details) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Debt Disclosure [Abstract] | ||
Federal Home Loan Bank advances | $ 22,500 | $ 22,500 |
Paycheck Protection Program Liquidity Facility | 60,602 | 106,789 |
Other borrowings | 37,542 | 37,792 |
Total borrowings | $ 120,644 | $ 167,081 |
Borrowings - (Details Textual)
Borrowings - (Details Textual) | Apr. 20, 2020USD ($) | May 01, 2019USD ($)arrangement | Mar. 31, 2021USD ($) | Dec. 31, 2020USD ($) |
Debt Instrument [Line Items] | ||||
Lendable collateral of loans | $ 88,600,000 | |||
Remaining credit available | 417,700,000 | |||
Number of borrowing arrangements entered into | arrangement | 2 | |||
Outstanding balance on line of credit | 0 | |||
Paycheck Protection Program Liquidity Facility | 60,602,000 | $ 106,789,000 | ||
Line of credit, current borrowing capacity | 41,500,000 | |||
Subordinated debt | 24,200,000 | $ 24,200,000 | ||
Federal Reserve Bank Advances | ||||
Debt Instrument [Line Items] | ||||
Short-term debt, borrowing capacity | 0 | |||
Paycheck Protection Program, CARES Act | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, stated interest rate | 0.35% | |||
Proceeds from line of credit | $ 140,700,000 | |||
Term Note | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, stated interest rate | 4.70% | |||
Notes payable balance | 8,000,000 | |||
Line of credit, maximum amount | $ 10,000,000 | |||
Revolving Credit Facility | ||||
Debt Instrument [Line Items] | ||||
Maximum borrowing capacity | $ 10,000,000 | |||
Outstanding balance on line of credit | $ 5,300,000 | |||
Revolving Credit Facility | Prime Rate | ||||
Debt Instrument [Line Items] | ||||
Basis spread on variable rate | 0.40% | |||
Minimum | ||||
Debt Instrument [Line Items] | ||||
FHLB interest rate | 1.05% | |||
Minimum | Paycheck Protection Program, CARES Act | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, term | 2 years | |||
Maximum | ||||
Debt Instrument [Line Items] | ||||
FHLB interest rate | 3.51% | |||
Maximum | Paycheck Protection Program, CARES Act | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, term | 5 years | |||
Weighted Average | Paycheck Protection Program, CARES Act | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, term | 2 years |
Borrowings - Aggregate Stated M
Borrowings - Aggregate Stated Maturities (Details) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Long-term Debt, Fiscal Year Maturity [Abstract] | ||
PPPLF | $ 60,602 | $ 106,789 |
Long-term Debt | 120,644 | |
Other borrowings | ||
Long-term Debt, Fiscal Year Maturity [Abstract] | ||
2021 | 5,313 | |
2022 | 0 | |
2023 | 3,000 | |
2024 | 8,000 | |
2025 | 4,500 | |
2026 and After | $ 39,229 |
Earnings Per Share - Summary of
Earnings Per Share - Summary of Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Numerator | ||
Net income available to common stockholders | $ 4,919 | $ 1,603 |
Weighted average number of common shares | ||
Outstanding for basic earnings per common share (in shares) | 9,498,783 | 9,498,783 |
Weighted-average number of shares outstanding for diluted earnings per common share (in shares) | 9,498,783 | 9,498,783 |
Earnings per share - basic (in dollars per share) | $ 0.52 | $ 0.17 |
Earnings per share - diluted (in dollars per share) | $ 0.52 | $ 0.17 |
Commitments and Contingencies -
Commitments and Contingencies - Financial Instruments Outstanding Whose Contract Amount Represents Credit Risk (Details) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Other Commitments [Line Items] | ||
Letters of credit | $ 4,342 | $ 3,634 |
Loan Origination Commitments | ||
Other Commitments [Line Items] | ||
Loan commitments | $ 235,074 | $ 198,029 |
Commitments and Contingencies_2
Commitments and Contingencies (Details Textual) | 3 Months Ended |
Mar. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
Letter of credit, expiration date period (in years) | 1 year |
Fair Value of Financial Instr_3
Fair Value of Financial Instruments and Fair Value Measurements - Financial Instruments (Details) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Assets | ||
Investment securities available for sale, at fair value | $ 433,729 | $ 380,814 |
Carrying Value | ||
Assets | ||
Cash and short-term investments | 181,588 | 183,506 |
Investment securities available for sale, at fair value | 433,729 | 380,814 |
Other investments, at cost | 2,703 | 3,296 |
Loans held for sale | 28,429 | 52,386 |
Loans, net | 1,050,082 | 1,047,376 |
Liabilities | ||
Deposits | 1,525,884 | 1,445,027 |
Federal Home Loan Bank advances | 22,500 | 22,500 |
Carrying Value | Paycheck Protection Program Liquidity Facility | ||
Liabilities | ||
Long-term debt | 60,602 | 106,789 |
Carrying Value | Other borrowings | ||
Liabilities | ||
Long-term debt | 37,542 | 37,792 |
Estimated Fair Value | ||
Assets | ||
Cash and short-term investments | 181,588 | 183,506 |
Investment securities available for sale, at fair value | 433,729 | 380,814 |
Other investments, at cost | 2,703 | 3,296 |
Loans held for sale | 28,429 | 52,386 |
Loans, net | 1,061,554 | 1,063,785 |
Liabilities | ||
Deposits | 1,526,740 | 1,445,984 |
Federal Home Loan Bank advances | 21,312 | 20,817 |
Estimated Fair Value | Paycheck Protection Program Liquidity Facility | ||
Liabilities | ||
Long-term debt | 60,602 | 106,789 |
Estimated Fair Value | Other borrowings | ||
Liabilities | ||
Long-term debt | 37,767 | 37,792 |
Estimated Fair Value | Level 1 | ||
Assets | ||
Cash and short-term investments | 181,588 | 183,506 |
Investment securities available for sale, at fair value | 0 | 245 |
Other investments, at cost | 0 | 0 |
Loans held for sale | 0 | 0 |
Loans, net | 0 | 0 |
Liabilities | ||
Deposits | 0 | 0 |
Federal Home Loan Bank advances | 0 | 0 |
Estimated Fair Value | Level 1 | Paycheck Protection Program Liquidity Facility | ||
Liabilities | ||
Long-term debt | 0 | 0 |
Estimated Fair Value | Level 1 | Other borrowings | ||
Liabilities | ||
Long-term debt | 0 | 0 |
Estimated Fair Value | Level 2 | ||
Assets | ||
Cash and short-term investments | 0 | 0 |
Investment securities available for sale, at fair value | 433,729 | 380,569 |
Other investments, at cost | 2,703 | 3,296 |
Loans held for sale | 28,429 | 52,386 |
Loans, net | 0 | 0 |
Liabilities | ||
Deposits | 1,526,740 | 1,445,984 |
Federal Home Loan Bank advances | 21,312 | 20,817 |
Estimated Fair Value | Level 2 | Paycheck Protection Program Liquidity Facility | ||
Liabilities | ||
Long-term debt | 60,602 | 106,789 |
Estimated Fair Value | Level 2 | Other borrowings | ||
Liabilities | ||
Long-term debt | 37,767 | 37,792 |
Estimated Fair Value | Level 3 | ||
Assets | ||
Cash and short-term investments | 0 | 0 |
Investment securities available for sale, at fair value | 0 | 0 |
Other investments, at cost | 0 | 0 |
Loans held for sale | 0 | 0 |
Loans, net | 1,061,554 | 1,063,785 |
Liabilities | ||
Deposits | 0 | 0 |
Federal Home Loan Bank advances | 0 | 0 |
Estimated Fair Value | Level 3 | Paycheck Protection Program Liquidity Facility | ||
Liabilities | ||
Long-term debt | 0 | |
Estimated Fair Value | Level 3 | Other borrowings | ||
Liabilities | ||
Long-term debt | $ 0 | $ 0 |
Fair Value of Financial Instr_4
Fair Value of Financial Instruments and Fair Value Measurements - Narrative (Details) | Mar. 31, 2021 |
Fair Value Disclosures [Abstract] | |
Fair value input, discount amount | 10.00% |
Fair Value of Financial Instr_5
Fair Value of Financial Instruments and Fair Value Measurements - Assets and Liabilities Measured at Fair Value on a Recurring and Nonrecurring Basis (Details) - Nonrecurring - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Collateral dependent impaired loans | $ 4,984 | $ 5,939 |
Other real estate owned | 518 | 1,006 |
Total nonrecurring assets | 5,502 | 6,945 |
Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Collateral dependent impaired loans | 0 | 0 |
Other real estate owned | 0 | 0 |
Total nonrecurring assets | 0 | 0 |
Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Collateral dependent impaired loans | 0 | 0 |
Other real estate owned | 0 | 0 |
Total nonrecurring assets | 0 | 0 |
Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Collateral dependent impaired loans | 4,984 | 5,939 |
Other real estate owned | 518 | 1,006 |
Total nonrecurring assets | $ 5,502 | $ 6,945 |
Fair Value of Financial Instr_6
Fair Value of Financial Instruments and Fair Value Measurements - Quantitative Information for Financial Instruments Measured at Fair Value (Details) $ in Thousands | Mar. 31, 2021USD ($) | Dec. 31, 2020USD ($) |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Other real estate owned | $ 518 | $ 1,006 |
Nonrecurring | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Collateral dependent impaired loans | 4,984 | 5,939 |
Level 3 | Nonrecurring | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Collateral dependent impaired loans | 4,984 | 5,939 |
Other real estate owned | $ 518 | $ 1,006 |
Level 3 | Nonrecurring | Minimum | Measurement Input, Appraised Value | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Collateral Dependent Impaired Loans, Weighted Average Discount Range | 0.25 | 0.25 |
Other Real Estate Owned, Weighted Average Discount Range | 0 | 0 |
Level 3 | Nonrecurring | Maximum | Measurement Input, Appraised Value | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Collateral Dependent Impaired Loans, Weighted Average Discount Range | 1 | 1 |
Other Real Estate Owned, Weighted Average Discount Range | 0.20 | 0.20 |
Fair Value of Financial Instr_7
Fair Value of Financial Instruments and Fair Value Measurements - Fair Value Measurement Using Significant Unobservable Inputs (Details) - Available for Sale Securities $ in Thousands | 3 Months Ended |
Mar. 31, 2020USD ($) | |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |
Balance, Beginning | $ 2,022 |
Transfers out of Level 3 | 0 |
Sales | 0 |
Paydowns | (5) |
Realized Loss on Sale of Security | 0 |
Unrealized gains (losses) included in Other Comprehensive Income | 0 |
Balance, Ending | $ 2,017 |
Segment Information - Schedule
Segment Information - Schedule of Segment Reporting Information (Details) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2021USD ($)employee | Mar. 31, 2020USD ($)employee | Dec. 31, 2020USD ($) | |
Segment Reporting Information [Line Items] | |||
Net Interest Income | $ 14,283 | $ 12,704 | |
Provision | 500 | 1,956 | |
Noninterest Income | 8,576 | 4,526 | |
Noninterest Expenses | 15,782 | 13,343 | |
Income Taxes | 1,658 | 328 | |
Segment Profit (Loss) | 4,919 | 1,603 | |
Segment Assets | $ 1,799,046 | $ 1,763,974 | $ 1,763,974 |
Full time employees | employee | 365 | 365 | |
Bank | |||
Segment Reporting Information [Line Items] | |||
Net Interest Income | $ 13,985 | $ 12,656 | |
Provision | 500 | 1,956 | |
Noninterest Income | 3,005 | 3,014 | |
Noninterest Expenses | 11,960 | 11,632 | |
Income Taxes | 1,160 | 368 | |
Segment Profit (Loss) | 3,370 | 1,714 | |
Segment Assets | $ 1,755,667 | $ 1,709,696 | |
Full time employees | employee | 291 | 319 | |
Mortgage Banking | |||
Segment Reporting Information [Line Items] | |||
Net Interest Income | $ 168 | $ 34 | |
Provision | 0 | 0 | |
Noninterest Income | 3,986 | 1,253 | |
Noninterest Expenses | 2,793 | 1,195 | |
Income Taxes | 354 | 11 | |
Segment Profit (Loss) | 1,007 | 81 | |
Segment Assets | $ 27,478 | $ 50,266 | |
Full time employees | employee | 51 | 34 | |
Small Business Specialty Lending Division | |||
Segment Reporting Information [Line Items] | |||
Net Interest Income | $ 130 | $ 14 | |
Provision | 0 | 0 | |
Noninterest Income | 1,585 | 259 | |
Noninterest Expenses | 1,029 | 516 | |
Income Taxes | 144 | (51) | |
Segment Profit (Loss) | 542 | (465) | |
Segment Assets | $ 15,901 | $ 4,012 | |
Full time employees | employee | 23 | 12 |
Regulatory Capital Matters (Det
Regulatory Capital Matters (Details Textual) | Jan. 01, 2016 |
Banking And Thrift Disclosure [Abstract] | |
Percentage of risk-weighted assets (as a percent) | 0.625% |
Increase in percentage of risk-weighted assets (as a percent) | 0.625% |
Final level of percentage of risk-weighted assets (as a percent) | 2.50% |
Regulatory Capital Matters - Su
Regulatory Capital Matters - Summary of Regulatory Capital Information (Details) $ in Thousands | Mar. 31, 2021USD ($) | Dec. 31, 2020USD ($) |
Total Capital to Risk-Weighted Assets | ||
Actual Amount | $ 159,767 | $ 155,447 |
Actual Ratio | 0.1376 | 0.1378 |
For Capital Adequacy Purposes, Amount | $ 92,888 | $ 90,245 |
For Capital Adequacy Purposes, Ratio | 0.0800 | 0.0800 |
Tier I Capital to Risk-Weighted Assets | ||
Actual Amount | $ 147,074 | $ 143,320 |
Actual Ratio | 0.1249 | 0.1271 |
For Capital Adequacy Purposes, Amount | $ 70,652 | $ 67,657 |
For Capital Adequacy Purposes, Ratio | 0.0600 | 0.0600 |
Common Equity Tier I Capital to Risk-Weighted Assets | ||
Actual Amount | $ 123,574 | $ 119,820 |
Actual Ratio | 0.1049 | 0.1062 |
For Capital Adequacy Purposes, Amount | $ 53,011 | $ 50,771 |
For Capital Adequacy Purposes, Ratio | 4.50% | 4.50% |
Tier I Capital to Average Assets | ||
Actual Amount | $ 147,074 | $ 143,320 |
Actual Ratio | 0.0870 | 0.0849 |
For Capital Adequacy Purposes, Amount | $ 67,620 | $ 67,524 |
For Capital Adequacy Purposes, Ratio | 0.0400 | 0.0400 |
Colony Bank | ||
Total Capital to Risk-Weighted Assets | ||
Actual Amount | $ 163,639 | $ 164,050 |
Actual Ratio | 0.1381 | 0.1455 |
For Capital Adequacy Purposes, Amount | $ 94,794 | $ 90,199 |
For Capital Adequacy Purposes, Ratio | 0.0800 | 0.0800 |
To Be Well Capitalized Under Prompt Corrective Action Provisions, Amount | $ 118,493 | $ 112,749 |
To Be Well Capitalized Under Prompt Corrective Action Provisions, Ratio | 0.1000 | 0.1000 |
Tier I Capital to Risk-Weighted Assets | ||
Actual Amount | $ 150,946 | $ 151,923 |
Actual Ratio | 0.1274 | 0.1348 |
For Capital Adequacy Purposes, Amount | $ 71,089 | $ 67,622 |
For Capital Adequacy Purposes, Ratio | 0.0600 | 0.0600 |
To Be Well Capitalized Under Prompt Corrective Action Provisions, Amount | $ 94,786 | $ 90,162 |
To Be Well Capitalized Under Prompt Corrective Action Provisions, Ratio | 0.0800 | 0.0800 |
Common Equity Tier I Capital to Risk-Weighted Assets | ||
Actual Amount | $ 150,946 | $ 151,923 |
Actual Ratio | 0.1274 | 0.1348 |
For Capital Adequacy Purposes, Amount | $ 53,317 | $ 50,716 |
For Capital Adequacy Purposes, Ratio | 4.50% | 4.50% |
To Be Well Capitalized Under Prompt Corrective Action Provisions, Amount | $ 77,013 | $ 73,257 |
To Be Well Capitalized Under Prompt Corrective Action Provisions, Ratio | 6.50% | 6.50% |
Tier I Capital to Average Assets | ||
Actual Amount | $ 150,946 | $ 151,923 |
Actual Ratio | 0.0905 | 0.0912 |
For Capital Adequacy Purposes, Amount | $ 66,716 | $ 66,633 |
For Capital Adequacy Purposes, Ratio | 0.0400 | 0.0400 |
To Be Well Capitalized Under Prompt Corrective Action Provisions, Amount | $ 83,396 | $ 83,291 |
To Be Well Capitalized Under Prompt Corrective Action Provisions, Ratio | 0.0500 | 0.0500 |
Subsequent Events (Details)
Subsequent Events (Details) - USD ($) $ / shares in Units, $ in Millions | Apr. 22, 2021 | Mar. 31, 2021 | Mar. 31, 2020 | Apr. 21, 2021 |
Subsequent Event [Line Items] | ||||
Dividends declared per share (in dollars per share) | $ 0.1025 | $ 0.10 | ||
Subsequent Event | ||||
Subsequent Event [Line Items] | ||||
Stock price (in dollars per share) | $ 15 | |||
Dividends declared per share (in dollars per share) | $ 0.1025 | |||
Subsequent Event | SouthCrest Financial Group, Inc. | ||||
Subsequent Event [Line Items] | ||||
Percentage of business acquired | 100.00% | |||
Value of combined stock-and-cash transaction | $ 84 | |||
Assets acquired | 2,400 | |||
Loans acquired | 1,400 | |||
Deposits acquired | 2,000 | |||
Tangible common equity acquired | $ 165.8 | |||
Cash paid in exchange for each share (in dollars per share) | $ 10.45 | |||
Shares exchanged for each share (in shares) | 0.7318 | |||
Percentage of shares that will be converted to cash consideration | 27.50% | |||
Percentage of shares that will be converted to common stock | 72.50% | |||
Merger consideration price (in dollars per share) | $ 10.83 |